data_1ayg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ayg _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.539 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 79' ' ' ILE . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.543 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 HG13 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' HG11 ' A' ' 53' ' ' VAL . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.426 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.474 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.449 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' HG13 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.554 ' CE2' HD13 ' A' ' 79' ' ' ILE . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.554 HD13 ' CE2' ' A' ' 75' ' ' TRP . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.213 0.53 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.462 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.508 ' CD1' HD13 ' A' ' 77' ' ' LEU . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 41' ' ' TYR . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 46' ' ' ILE . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.536 HD12 ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.469 0.652 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.429 ' HB2' ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.502 ' CD2' HD11 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 42' ' ' LEU . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.491 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.439 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.53 ' CZ2' HD12 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 25' ' ' TYR . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.53 HD12 ' CZ2' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.419 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.507 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.511 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD2' ' HB1' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 ' CD1' ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HA ' HD11 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.463 ' CB ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' SER . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.437 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.527 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 25' ' ' TYR . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD1' HD13 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' HD12 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.48 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HD3' ' CG1' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.1 m-70 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 28' ' ' VAL . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' CG ' ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.477 ' CG ' ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 42' ' ' LEU . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' C ' ' O ' ' A' ' 56' ' ' SER . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.403 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' OE1' HG23 ' A' ' 39' ' ' VAL . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.507 ' CE2' HD13 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.507 HD13 ' CE2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.225 0.536 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' OE1' ' A' ' 71' ' ' GLN . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE1' HD12 ' A' ' 76' ' ' ILE . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.483 ' O ' ' O ' ' A' ' 29' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' ALA . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.557 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.524 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.412 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.533 ' CE2' HD13 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 25' ' ' TYR . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 29' ' ' ALA . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.492 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' ASP . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' LYS . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.566 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 36' ' ' LYS . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.499 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.503 ' O ' ' CG ' ' A' ' 42' ' ' LEU . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' CG ' ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG11 ' O ' ' A' ' 53' ' ' VAL . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 11' ' ' MET . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HB1' ' A' ' 12' ' ' ALA . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.457 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 9' ' ' GLY . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.409 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CE1' HD12 ' A' ' 76' ' ' ILE . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 73' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 43' ' ' ALA . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 68' ' ' GLU . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.468 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.479 HD12 ' CE1' ' A' ' 25' ' ' TYR . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 25' ' ' TYR . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.551 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.564 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HE3' HG23 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 54' ' ' TRP . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.487 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.531 ' OE1' ' CG1' ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HG3' HG13 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB3' HD13 ' A' ' 46' ' ' ILE . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 HD12 HD23 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.531 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 46' ' ' ILE . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.498 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.408 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 ' OE2' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' CD1' ' OE1' ' A' ' 68' ' ' GLU . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CZ3' ' HB1' ' A' ' 5' ' ' ALA . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 79' ' ' ILE . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 46' ' ' ILE . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.452 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' ' CB ' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.492 HG21 ' N ' ' A' ' 80' ' ' LYS . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HA ' HD21 ' A' ' 4' ' ' LEU . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.485 ' ND1' ' CE1' ' A' ' 25' ' ' TYR . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CE1' ' ND1' ' A' ' 14' ' ' HIS . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.453 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 46' ' ' ILE . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 42' ' ' LEU . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' O ' HD13 ' A' ' 77' ' ' LEU . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.449 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 73' ' ' ALA . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.461 HG22 ' CD2' ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.359 0.599 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.402 HD11 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.553 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.488 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 46' ' ' ILE . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 42' ' ' LEU . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.444 ' HE1' ' OE1' ' A' ' 62' ' ' GLN . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.444 ' OE1' ' HE1' ' A' ' 59' ' ' MET . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.553 ' CE2' HD13 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.475 HD23 ' OE1' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HG ' ' CG2' ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 43' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.572 ' CE ' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 43' ' ' ALA . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 53' ' ' VAL . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.585 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.48 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.475 ' OE1' HD23 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.499 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.466 ' O ' HG13 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 25' ' ' TYR . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 16' ' ' LEU . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 71' ' ' GLN . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' HG11 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 79' ' ' ILE . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 19' ' ' LYS . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 42' ' ' LEU . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' A' ' 64' ' ' VAL . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.518 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 47' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 76' ' ' ILE . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.563 ' CE2' HD13 ' A' ' 79' ' ' ILE . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.503 HD12 ' CE1' ' A' ' 25' ' ' TYR . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.563 HD13 ' CE2' ' A' ' 75' ' ' TRP . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.453 HD23 HD11 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.449 ' HB3' ' OXT' ' A' ' 80' ' ' LYS . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.543 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 42' ' ' LEU . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.412 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 56' ' ' SER . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.564 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.511 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LEU . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.559 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 79' ' ' ILE . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' OXT' ' HB3' ' A' ' 26' ' ' ALA . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' OE1' ' A' ' 71' ' ' GLN . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.565 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 74' ' ' GLN . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' GLY . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 56' ' ' SER . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.594 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' HG12 ' A' ' 39' ' ' VAL . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 29' ' ' ALA . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CD1' HD23 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 79' ' ' ILE . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HD3' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' ASP . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 26' ' ' ALA . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 36' ' ' LYS . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' ALA . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.431 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.526 ' CG1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.526 ' OE1' ' CG1' ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HA ' HD11 ' A' ' 72' ' ' LEU . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.477 HD22 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 25' ' ' TYR . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.442 ' HE2' HD11 ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 19' ' ' LYS . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.475 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' LEU . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 46' ' ' ILE . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 54' ' ' TRP . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 51' ' ' SER . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.411 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.548 ' CE2' HD13 ' A' ' 79' ' ' ILE . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.548 HD13 ' CE2' ' A' ' 75' ' ' TRP . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.467 ' N ' HG21 ' A' ' 79' ' ' ILE . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 12' ' ' ALA . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.433 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 9' ' ' GLY . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB1' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.433 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' A' ' 46' ' ' ILE . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 42' ' ' LEU . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.515 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 53' ' ' VAL . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.515 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . 0.454 ' HE3' ' O ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' O ' ' HE3' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.403 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' TRP . . . . . 0.479 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 79' ' ' ILE . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.332 0.587 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.07 -41.75 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.439 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.539 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.51 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.488 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 79' ' ' ILE . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.467 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.573 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.543 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 HG13 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' A' ' 43' ' ' ALA . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 61' ' ' PRO . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.416 ' O ' HG11 ' A' ' 53' ' ' VAL . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.426 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.474 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.474 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 48' ' ' LYS . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.449 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.413 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' HG13 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.554 ' CE2' HD13 ' A' ' 79' ' ' ILE . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.554 HD13 ' CE2' ' A' ' 75' ' ' TRP . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.487 HAD2 ' CD1' ' A' ' 54' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.514 ' N ' HD22 ' A' ' 4' ' ' LEU . 6.8 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 1' ' ' ASN . 39.4 tt0 -178.69 -40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.695 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 1' ' ' ASN . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.516 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.468 ' HB1' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' HG3' ' HB1' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.536 ' CE1' HD12 ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.462 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.49 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.535 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.508 ' CD1' HD13 ' A' ' 77' ' ' LEU . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HE2' ' CZ ' ' A' ' 41' ' ' TYR . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.471 HG23 HD11 ' A' ' 46' ' ' ILE . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.487 ' HA3' ' CGD' ' A' ' 81' ' ' HEC . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.413 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.467 ' CG ' HBB1 ' A' ' 81' ' ' HEC . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.482 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.448 ' HB2' HD11 ' A' ' 42' ' ' LEU . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.482 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.536 HD12 ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.487 ' CGD' ' HA3' ' A' ' 50' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.06 99.38 3.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' HB2' ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.462 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.439 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.502 ' CD2' HD11 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.532 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.423 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' O ' HD13 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' CG1' HMA1 ' A' ' 81' ' ' HEC . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.459 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.532 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.491 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' HB2' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.498 ' HA ' ' HG2' ' A' ' 74' ' ' GLN . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.439 ' O ' HD11 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' VAL . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.498 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.53 ' CZ2' HD12 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.488 HD12 ' CD1' ' A' ' 25' ' ' TYR . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.53 HD12 ' CZ2' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.523 HMA1 ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 -61.14 176.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.292 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.419 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.43 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.507 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' OD2' ' HB1' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.533 HD12 ' CD1' ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.456 ' HB1' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.507 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.45 ' HB3' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.449 ' HA ' ' CD2' ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.48 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD13 ' CD1' ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.476 ' HA ' HD11 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.476 HD11 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.463 ' CB ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.461 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 ' O ' ' HB3' ' A' ' 51' ' ' SER . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.507 ' HE2' ' NB ' ' A' ' 81' ' ' HEC . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HG3' ' CBB' ' A' ' 81' ' ' HEC . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.527 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.437 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.527 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD1' ' A' ' 25' ' ' TYR . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.512 ' CD1' HD13 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 ' CD1' HD12 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.45 ' HG3' ' HB3' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.583 ' NA ' ' NE2' ' A' ' 14' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.408 ' OD1' ' N ' ' A' ' 1' ' ' ASN . 1.4 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -96.95 119.12 34.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.865 . . . . 0.0 109.598 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.48 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.48 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HB3' HBB2 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.41 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.1 m-70 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 16' ' ' LEU . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' CB ' ' O ' ' A' ' 15' ' ' ASP . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.437 ' HD2' ' CE1' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' O ' HG22 ' A' ' 28' ' ' VAL . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.466 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HA ' HD21 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' O ' ' CG ' ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.451 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.477 ' CG ' ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.523 ' CG1' HMA1 ' A' ' 81' ' ' HEC . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.472 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' HG3' HBB3 ' A' ' 81' ' ' HEC . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.403 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' A' ' 71' ' ' GLN . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' OE1' HG23 ' A' ' 39' ' ' VAL . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.507 ' CE2' HD13 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.507 HD13 ' CE2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.523 HMA1 ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.3 p30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -176.41 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.867 . . . . 0.0 109.682 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD12 ' OE1' ' A' ' 71' ' ' GLN . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.458 HD21 HG22 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.557 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.558 ' CE1' HD12 ' A' ' 76' ' ' ILE . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.424 HG12 ' CGA' ' A' ' 81' ' ' HEC . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.483 ' O ' ' O ' ' A' ' 29' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 HD21 ' O1A' ' A' ' 81' ' ' HEC . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' HB2' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.447 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.557 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG23 HMD3 ' A' ' 81' ' ' HEC . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.524 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.473 ' HG3' HBB1 ' A' ' 81' ' ' HEC . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.488 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.49 HD12 ' CMB' ' A' ' 81' ' ' HEC . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.422 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.533 ' CE2' HD13 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.558 HD12 ' CE1' ' A' ' 25' ' ' TYR . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 29' ' ' ALA . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.533 HD13 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.49 ' CMB' HD12 ' A' ' 72' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.575 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 68.3 m-80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.243 0.544 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.1 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.868 . . . . 0.0 109.659 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.486 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.493 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.421 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.492 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB3' ' O ' ' A' ' 14' ' ' HIS . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.427 ' O ' ' C ' ' A' ' 19' ' ' LYS . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.571 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.562 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.566 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.471 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.499 ' HG2' ' N ' ' A' ' 36' ' ' LYS . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.499 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.503 ' O ' ' CG ' ' A' ' 42' ' ' LEU . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' CG ' ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.454 HG13 ' O2A' ' A' ' 81' ' ' HEC . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.571 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.49 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.508 ' HG3' ' CBB' ' A' ' 81' ' ' HEC . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.414 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.429 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' CZ2' ' O ' ' A' ' 1' ' ' ASN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.562 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.471 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.518 HG22 ' CD1' ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.635 ' NA ' ' NE2' ' A' ' 14' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 70.0 m-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.359 0.6 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 -146.26 165.49 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 11' ' ' MET . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HG2' ' CBB' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.468 ' O ' ' HB1' ' A' ' 12' ' ' ALA . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.492 ' CG ' ' HB2' ' A' ' 5' ' ' ALA . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 9' ' ' GLY . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.414 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.409 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.417 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.479 ' CE1' HD12 ' A' ' 76' ' ' ILE . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.414 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.559 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 73' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.491 ' HB3' ' CB ' ' A' ' 69' ' ' ALA . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.427 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.449 HD11 ' HA ' ' A' ' 43' ' ' ALA . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.431 ' HE2' ' NC ' ' A' ' 81' ' ' HEC . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.401 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' CB ' ' HB3' ' A' ' 43' ' ' ALA . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 68' ' ' GLU . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' HB3' HD11 ' A' ' 42' ' ' LEU . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.487 ' CZ2' ' O ' ' A' ' 1' ' ' ASN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.479 HD12 ' CE1' ' A' ' 25' ' ' TYR . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' N ' ' CG2' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.526 ' CBB' ' HG2' ' A' ' 8' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 56.86 29.31 15.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.415 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.467 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.483 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 25' ' ' TYR . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.466 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.562 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.551 ' HD3' ' CH2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.564 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.455 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.422 HG13 ' HG3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HE3' HG23 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.557 HG13 ' CD1' ' A' ' 54' ' ' TRP . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.463 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' C ' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.534 ' HE2' ' NB ' ' A' ' 81' ' ' HEC . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.531 ' CG1' ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.531 ' OE1' ' CG1' ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.422 ' HG3' HG13 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.42 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.435 ' HB3' HD13 ' A' ' 46' ' ' ILE . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.493 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.559 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 HD12 HD23 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.534 ' NB ' ' HE2' ' A' ' 59' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.579 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.32 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.531 ' HB1' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.606 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.498 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.46 ' O ' HG13 ' A' ' 46' ' ' ILE . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.498 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.408 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.455 HG13 ' OE2' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.534 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.534 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.528 ' CD1' ' OE1' ' A' ' 68' ' ' GLU . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.531 ' CZ3' ' HB1' ' A' ' 5' ' ' ALA . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.553 HD12 ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 79' ' ' ILE . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 79' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.606 ' NA ' ' NE2' ' A' ' 14' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.51 16.3 26.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.403 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.533 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.451 HD23 HD12 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.528 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.555 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG21 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.562 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' CG1' ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.497 HD11 HG22 ' A' ' 46' ' ' ILE . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.562 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.416 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.528 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.452 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.409 ' O ' ' OD1' ' A' ' 66' ' ' ASP . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.475 ' HG2' ' CG1' ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.505 ' HG3' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.505 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HB3' ' CB ' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.498 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.555 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.492 HG21 ' N ' ' A' ' 80' ' ' LYS . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 79' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.528 ' ND ' ' SD ' ' A' ' 59' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -179.57 -34.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.343 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.423 ' HA ' HD21 ' A' ' 4' ' ' LEU . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.573 ' HB3' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.435 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.526 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 20' ' ' LYS . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.418 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.485 ' CE1' ' ND1' ' A' ' 14' ' ' HIS . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' ' HB2' ' A' ' 35' ' ' ARG . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.453 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.464 ' O ' HG13 ' A' ' 46' ' ' ILE . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HB3' ' HB2' ' A' ' 69' ' ' ALA . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.489 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.531 ' CG1' HMA1 ' A' ' 81' ' ' HEC . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG13 ' CMD' ' A' ' 81' ' ' HEC . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.462 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.462 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.419 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 43' ' ' ALA . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.506 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' O ' HD13 ' A' ' 77' ' ' LEU . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.449 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 73' ' ' ALA . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.461 HG22 ' CD2' ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.531 HMA1 ' CG1' ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -131.15 138.34 49.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.402 HD11 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.449 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.406 ' O ' ' HE3' ' A' ' 20' ' ' LYS . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.564 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.553 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 20' ' ' LYS . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.553 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.527 ' HB2' ' CD1' ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.488 ' HB2' ' CB ' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.488 ' CB ' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.456 HD21 HMA3 ' A' ' 81' ' ' HEC . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 42' ' ' LEU . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.444 ' HE1' ' OE1' ' A' ' 62' ' ' GLN . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.503 ' HG2' ' CBB' ' A' ' 81' ' ' HEC . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.428 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.513 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.553 ' CE2' HD13 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.503 ' CBB' ' HG2' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -118.77 75.67 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.475 HD23 ' OE1' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.45 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.527 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.52 ' HG ' ' CG2' ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.425 ' N ' ' CG ' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.432 ' HA2' HMD1 ' A' ' 81' ' ' HEC . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.585 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CE1' HD12 ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.426 ' O ' HD11 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.437 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.572 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 43' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' CE ' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.47 ' CD1' HMA3 ' A' ' 81' ' ' HEC . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.465 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 53' ' ' VAL . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.585 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 HG11 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.465 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.48 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.485 ' O ' ' CD1' ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.475 ' OE1' HD23 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.499 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.466 ' O ' HG13 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.567 HD12 ' CE1' ' A' ' 25' ' ' TYR . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.52 ' CG2' ' HG ' ' A' ' 16' ' ' LEU . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.523 ' CBC' HMC2 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.26 85.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.42 HD11 ' OE1' ' A' ' 71' ' ' GLN . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HE3' HG11 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 14' ' ' HIS . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.402 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.476 ' CD1' HG22 ' A' ' 79' ' ' ILE . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.407 ' O ' ' CB ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.444 ' N ' ' HB3' ' A' ' 19' ' ' LYS . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.525 ' O ' ' CD1' ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 42' ' ' LEU . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HG3' HG21 ' A' ' 64' ' ' VAL . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.518 ' O ' ' CG1' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HG3' ' CBB' ' A' ' 81' ' ' HEC . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 ' HG3' ' A' ' 47' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' HG13 ' A' ' 76' ' ' ILE . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.563 ' CE2' HD13 ' A' ' 79' ' ' ILE . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.503 HD12 ' CE1' ' A' ' 25' ' ' TYR . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.563 HD13 ' CE2' ' A' ' 75' ' ' TRP . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.528 ' CBB' ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.437 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 63.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.59 51.38 9.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.362 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.413 ' SG ' ' CMB' ' A' ' 81' ' ' HEC . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.453 HD23 HD11 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.494 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.559 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.449 ' HB3' ' OXT' ' A' ' 80' ' ' LYS . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 77' ' ' LEU . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.529 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.543 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 42' ' ' LEU . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.464 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.529 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.412 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.525 HG13 ' CMD' ' A' ' 81' ' ' HEC . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 56' ' ' SER . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.564 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.511 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LEU . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.496 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.559 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 29' ' ' ALA . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 79' ' ' ILE . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' OXT' ' HB3' ' A' ' 26' ' ' ALA . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.525 ' CMD' HG13 ' A' ' 57' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -103.59 88.63 3.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.441 HD23 ' OE1' ' A' ' 71' ' ' GLN . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.4 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.455 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.485 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.506 HD23 ' CD1' ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.563 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.429 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.565 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG12 ' HG3' ' A' ' 74' ' ' GLN . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.455 ' O ' ' N ' ' A' ' 44' ' ' GLY . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.509 ' CG1' HMA3 ' A' ' 81' ' ' HEC . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 56' ' ' SER . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.457 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.492 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.594 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.594 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.42 ' HG3' HG12 ' A' ' 39' ' ' VAL . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.495 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 29' ' ' ALA . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' CD1' HD23 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.446 ' N ' HG21 ' A' ' 79' ' ' ILE . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.514 ' CMC' HBC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 4.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.468 0.651 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.3 62.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.246 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HD3' HG13 ' A' ' 64' ' ' VAL . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.509 ' HB3' ' CB ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' ASP . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 26' ' ' ALA . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.562 ' CD1' HD12 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.416 ' HB2' ' HE2' ' A' ' 17' ' ' LYS . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' HA ' HD22 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.568 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.554 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.434 ' O ' ' C ' ' A' ' 36' ' ' LYS . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 ' O ' ' C ' ' A' ' 43' ' ' ALA . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.522 HG12 ' CMA' ' A' ' 81' ' ' HEC . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.449 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.526 ' CG1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' OE1' ' CG1' ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.417 ' HA ' HD11 ' A' ' 72' ' ' LEU . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.477 HD22 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.571 ' CE2' ' O ' ' A' ' 1' ' ' ASN . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.562 HD12 ' CD1' ' A' ' 25' ' ' TYR . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.522 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.357 0.598 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.93 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.46 ' SG ' HMB2 ' A' ' 81' ' ' HEC . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.442 ' HE2' HD11 ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.461 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.475 ' OD2' ' HB3' ' A' ' 19' ' ' LYS . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.505 ' O ' ' CB ' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.475 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' LYS . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.461 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.568 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.417 ' HB2' HD13 ' A' ' 16' ' ' LEU . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.556 ' O ' ' CB ' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.444 ' O ' HG13 ' A' ' 46' ' ' ILE . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.528 ' HA ' ' CD1' ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HB3' HBA1 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.429 ' HB2' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 54' ' ' TRP . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' HA ' ' HB2' ' A' ' 51' ' ' SER . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.411 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.456 ' HG3' ' CBB' ' A' ' 81' ' ' HEC . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.525 ' O ' ' CB ' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.548 ' CE2' HD13 ' A' ' 79' ' ' ILE . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.548 HD13 ' CE2' ' A' ' 75' ' ' TRP . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' N ' HG21 ' A' ' 79' ' ' ILE . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.531 ' CMC' HBC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 46.34 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.419 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.412 ' O ' ' HB1' ' A' ' 12' ' ' ALA . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.433 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 9' ' ' GLY . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.498 ' CB ' ' O ' ' A' ' 14' ' ' HIS . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.483 ' HB1' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG21 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG21 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.574 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' OD1' ' A' ' 15' ' ' ASP . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.433 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.41 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.463 ' HB3' HD13 ' A' ' 46' ' ' ILE . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.484 HG12 ' CMA' ' A' ' 81' ' ' HEC . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.515 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG11 ' O ' ' A' ' 53' ' ' VAL . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.574 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.515 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HE3' ' O ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' O ' ' HE3' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.47 ' HG3' ' CBB' ' A' ' 81' ' ' HEC . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.479 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' TRP . . . . . 0.479 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 79' ' ' ILE . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HEC . . . . . 0.484 ' CMA' HG12 ' A' ' 46' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.861 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.587 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.713 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 32' ' ' TYR . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.479 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.571 ' OE2' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD3' HG11 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 16' ' ' LEU . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.213 0.53 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.888 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.734 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 38' ' ' ALA . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.79 ' NZ ' HG11 ' A' ' 53' ' ' VAL . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 46' ' ' ILE . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 ' NZ ' ' A' ' 45' ' ' LYS . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 16' ' ' LEU . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.469 0.652 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.856 ' CD2' HD13 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.71 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 42' ' ' LEU . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.498 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' OE1' HD12 ' A' ' 4' ' ' LEU . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.812 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD23 ' HB1' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.856 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.438 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.535 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 57' ' ' VAL . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG12 ' OE1' ' A' ' 68' ' ' GLU . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' OE1' HG12 ' A' ' 64' ' ' VAL . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' ILE . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' LEU . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.842 HD11 HD12 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.682 HD13 HD11 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD3' ' CG1' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 23' ' ' PRO . 1.6 m80 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.67 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.752 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.564 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 42' ' ' LEU . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 51' ' ' SER . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 29' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.225 0.536 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.983 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 24' ' ' ALA . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 64' ' ' VAL . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 76' ' ' ILE . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.925 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 72' ' ' LEU . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 77' ' ' LEU . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.507 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.472 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD11 HD13 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG2' HG23 ' A' ' 21' ' ' VAL . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.617 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 72' ' ' LEU . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.643 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 17' ' ' LYS . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 80' ' ' LYS . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 69' ' ' ALA . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 32' ' ' TYR . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 24' ' ' ALA . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 38' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 45' ' ' LYS . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.49 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.78 HG12 ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.78 ' OE1' HG12 ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HE3' HG11 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 76' ' ' ILE . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 42' ' ' LEU . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.415 HD13 ' OE1' ' A' ' 71' ' ' GLN . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.636 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.804 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.636 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.448 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 32' ' ' TYR . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 57' ' ' VAL . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' CD1' ' OE1' ' A' ' 68' ' ' GLU . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.7 ' CE2' HD11 ' A' ' 79' ' ' ILE . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 75' ' ' TRP . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.855 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 77' ' ' LEU . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.575 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.48 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 65' ' ' THR . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.855 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.741 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.566 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 33' ' ' ALA . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.741 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 24' ' ' ALA . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 38' ' ' ALA . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.581 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 2.3 p-10 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 64' ' ' VAL . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 77' ' ' LEU . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.557 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 25' ' ' TYR . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 74' ' ' GLN . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.819 HG21 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.359 0.599 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.65 HD13 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.424 ' CE ' HD21 ' A' ' 16' ' ' LEU . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.788 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.908 HD12 HG21 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB2' HD13 ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ALA . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.677 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.986 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.986 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD21 ' HE2' ' A' ' 32' ' ' TYR . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' ALA . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.65 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.651 ' CE2' HD11 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.491 HD21 ' NE2' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.949 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG23 ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 77' ' ' LEU . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 38' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HE2' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 54' ' ' TRP . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.485 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' NE2' HD21 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 68' ' ' GLU . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.85 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' LEU . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 77' ' ' LEU . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 75' ' ' TRP . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 10' ' ' CYS . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB1' ' OXT' ' A' ' 80' ' ' LYS . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.643 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 42' ' ' LEU . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.661 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 8' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 69' ' ' ALA . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 72' ' ' LEU . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.554 ' CG2' HD13 ' A' ' 16' ' ' LEU . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' OXT' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.661 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.846 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.846 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.716 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 46' ' ' ILE . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 43' ' ' ALA . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.661 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 77' ' ' LEU . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.658 HG21 HD22 ' A' ' 16' ' ' LEU . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.667 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' HB2' HD23 ' A' ' 16' ' ' LEU . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 39' ' ' VAL . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 38' ' ' ALA . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 43' ' ' ALA . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.597 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 69' ' ' ALA . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HD12 ' A' ' 79' ' ' ILE . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 77' ' ' LEU . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.815 HG21 HD22 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.871 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.556 HD22 HD13 ' A' ' 79' ' ' ILE . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.871 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 42' ' ' LEU . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG11 ' OH ' ' A' ' 32' ' ' TYR . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.837 ' OE1' HG12 ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.759 HD23 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.759 ' CE3' HD23 ' A' ' 72' ' ' LEU . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 72' ' ' LEU . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 16' ' ' LEU . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.69 HD21 ' OE1' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.887 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 15' ' ' ASP . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 24' ' ' ALA . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 77' ' ' LEU . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 54' ' ' TRP . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.403 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 64' ' ' VAL . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.69 ' OE1' HD21 ' A' ' 4' ' ' LEU . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' GLN . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 42' ' ' LEU . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 16' ' ' LEU . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.928 HD21 ' NE2' ' A' ' 71' ' ' GLN . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.613 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 79' ' ' ILE . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HG2' HG23 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 24' ' ' ALA . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.682 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.996 ' CE2' HD21 ' A' ' 42' ' ' LEU . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 59' ' ' MET . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.511 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.511 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.928 ' NE2' HD21 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 29' ' ' ALA . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 16' ' ' LEU . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.332 0.587 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.07 -41.75 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.576 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.861 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.587 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.713 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 32' ' ' TYR . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.479 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' OE2' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD3' HG11 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 16' ' ' LEU . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.844 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.57 ' HB2' HD23 ' A' ' 4' ' ' LEU . 6.8 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -178.69 -40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 1' ' ' ASN . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.888 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.734 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 38' ' ' ALA . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.79 ' NZ ' HG11 ' A' ' 53' ' ' VAL . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.479 HG12 ' CMA' ' A' ' 81' ' ' HEC . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' HA3' ' CGD' ' A' ' 81' ' ' HEC . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 ' NZ ' ' A' ' 45' ' ' LYS . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.413 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 16' ' ' LEU . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.965 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.06 99.38 3.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.856 ' CD2' HD13 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.71 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 42' ' ' LEU . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.498 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' OE1' HD12 ' A' ' 4' ' ' LEU . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.812 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD23 ' HB1' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.856 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.932 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 -61.14 176.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.292 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.641 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.653 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 57' ' ' VAL . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.824 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG12 ' OE1' ' A' ' 68' ' ' GLU . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' OE1' HG12 ' A' ' 64' ' ' VAL . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' ILE . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' LEU . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.842 HD11 HD12 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.682 HD13 HD11 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.824 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -96.95 119.12 34.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.865 . . . . 0.0 109.598 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.5 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.1 m-70 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.67 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.752 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.761 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HD2' ' CE1' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG12 ' CMA' ' A' ' 81' ' ' HEC . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.482 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.812 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 29' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.812 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.402 ' O ' ' ND2' ' A' ' 1' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -176.41 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.867 . . . . 0.0 109.682 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.549 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.983 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 24' ' ' ALA . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.8 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 64' ' ' VAL . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 76' ' ' ILE . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.925 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 72' ' ' LEU . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 77' ' ' LEU . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.843 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.575 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 68.3 m-80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.243 0.544 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.1 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.868 . . . . 0.0 109.659 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.507 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.472 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD11 HD13 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG2' HG23 ' A' ' 21' ' ' VAL . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.617 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.583 HG11 ' O2A' ' A' ' 81' ' ' HEC . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.545 ' HE3' ' NB ' ' A' ' 81' ' ' HEC . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 72' ' ' LEU . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' CZ2' ' O ' ' A' ' 1' ' ' ASN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.889 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 70.0 m-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.359 0.6 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 -146.26 165.49 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 1.027 ' HG2' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.643 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 17' ' ' LYS . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 80' ' ' LYS . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.678 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 69' ' ' ALA . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 32' ' ' TYR . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 1.027 HBB1 ' HG2' ' A' ' 8' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 56.86 29.31 15.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.532 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 24' ' ' ALA . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 38' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 45' ' ' LYS . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.49 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.78 HG12 ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' OE1' HG12 ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HE3' HG11 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.3 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 76' ' ' ILE . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 42' ' ' LEU . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.874 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.579 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.32 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD13 ' OE1' ' A' ' 71' ' ' GLN . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HB2' HBB1 ' A' ' 81' ' ' HEC . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.527 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.606 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.636 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.804 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.636 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.448 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 32' ' ' TYR . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 57' ' ' VAL . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD13 HMB2 ' A' ' 81' ' ' HEC . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.7 ' CE2' HD11 ' A' ' 79' ' ' ILE . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 75' ' ' TRP . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.785 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.51 16.3 26.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.855 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 mm-40 -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 77' ' ' LEU . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.575 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.528 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.839 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 65' ' ' THR . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.855 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.741 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.566 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 33' ' ' ALA . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.741 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.839 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -179.57 -34.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.343 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.703 ' HD3' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.603 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.526 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 24' ' ' ALA . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 38' ' ' ALA . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.581 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.864 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.484 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 2.3 p-10 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 64' ' ' VAL . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.613 HD13 ' CMB' ' A' ' 81' ' ' HEC . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 77' ' ' LEU . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.557 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 25' ' ' TYR . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 74' ' ' GLN . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.819 HG21 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.864 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -131.15 138.34 49.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.65 HD13 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.424 ' CE ' HD21 ' A' ' 16' ' ' LEU . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.788 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.908 HD12 HG21 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB2' HD13 ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ALA . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.677 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.986 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.986 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD21 ' HE2' ' A' ' 32' ' ' TYR . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' ALA . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.949 ' HG2' HBB2 ' A' ' 81' ' ' HEC . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.65 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.651 ' CE2' HD11 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.982 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -118.77 75.67 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.491 HD21 ' NE2' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.949 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG23 ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 77' ' ' LEU . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 38' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HE2' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 54' ' ' TRP . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.485 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' NE2' HD21 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 68' ' ' GLU . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.85 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' LEU . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 77' ' ' LEU . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 75' ' ' TRP . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.84 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.26 85.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 10' ' ' CYS . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.539 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB1' ' OXT' ' A' ' 80' ' ' LYS . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.643 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 42' ' ' LEU . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.661 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 1.01 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 8' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 69' ' ' ALA . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 72' ' ' LEU . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.554 ' CG2' HD13 ' A' ' 16' ' ' LEU . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' OXT' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 1.01 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.464 ' N ' HD12 ' A' ' 4' ' ' LEU . 63.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.59 51.38 9.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.362 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.661 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.651 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.846 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.846 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.716 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 46' ' ' ILE . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 43' ' ' ALA . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.559 HG12 HMD2 ' A' ' 81' ' ' HEC . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.661 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 77' ' ' LEU . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.658 HG21 HD22 ' A' ' 16' ' ' LEU . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.762 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -103.59 88.63 3.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.518 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.667 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' HB2' HD23 ' A' ' 16' ' ' LEU . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 39' ' ' VAL . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 38' ' ' ALA . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 43' ' ' ALA . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.848 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.597 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 69' ' ' ALA . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HD12 ' A' ' 79' ' ' ILE . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 77' ' ' LEU . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.815 HG21 HD22 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.947 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 4.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.468 0.651 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.3 62.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.246 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.871 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.556 HD22 HD13 ' A' ' 79' ' ' ILE . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.871 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 42' ' ' LEU . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.536 HG12 ' CMA' ' A' ' 81' ' ' HEC . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG11 ' OH ' ' A' ' 32' ' ' TYR . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HMD1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.579 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.837 ' OE1' HG12 ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.759 HD23 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.759 ' CE3' HD23 ' A' ' 72' ' ' LEU . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 72' ' ' LEU . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 16' ' ' LEU . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.879 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.357 0.598 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.93 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.69 HD21 ' OE1' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.755 ' HG2' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.42 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.547 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.887 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 15' ' ' ASP . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 24' ' ' ALA . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 77' ' ' LEU . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HB3' HBA1 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG11 ' O2A' ' A' ' 81' ' ' HEC . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.403 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HB ' HMD1 ' A' ' 81' ' ' HEC . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.933 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 64' ' ' VAL . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.69 ' OE1' HD21 ' A' ' 4' ' ' LEU . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' GLN . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 42' ' ' LEU . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 16' ' ' LEU . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.933 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 46.34 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.928 HD21 ' NE2' ' A' ' 71' ' ' GLN . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.613 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 79' ' ' ILE . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HG2' HG23 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 24' ' ' ALA . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.682 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.996 ' CE2' HD21 ' A' ' 42' ' ' LEU . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 59' ' ' MET . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.511 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' HBD2 ' A' ' 81' ' ' HEC . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.511 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.415 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.821 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.928 ' NE2' HD21 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 29' ' ' ALA . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 16' ' ' LEU . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HEC . . . . . 0.873 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.861 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.587 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.713 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 32' ' ' TYR . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.479 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.438 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.571 ' OE2' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD3' HG11 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 16' ' ' LEU . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.213 0.53 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.888 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.734 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 38' ' ' ALA . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.79 ' NZ ' HG11 ' A' ' 53' ' ' VAL . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 46' ' ' ILE . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 ' NZ ' ' A' ' 45' ' ' LYS . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 16' ' ' LEU . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.469 0.652 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.856 ' CD2' HD13 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.71 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 42' ' ' LEU . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.498 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' OE1' HD12 ' A' ' 4' ' ' LEU . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.812 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.71 HD23 ' HB1' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.856 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.438 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.451 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.535 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 57' ' ' VAL . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.451 HG12 ' OE1' ' A' ' 68' ' ' GLU . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.451 ' OE1' HG12 ' A' ' 64' ' ' VAL . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' ILE . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' LEU . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.842 HD11 HD12 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.682 HD13 HD11 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD3' ' CG1' ' A' ' 64' ' ' VAL . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.1 m-70 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.67 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.752 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HD2' ' CE1' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 42' ' ' LEU . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.438 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' O ' ' HB3' ' A' ' 51' ' ' SER . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 29' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.225 0.536 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.511 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.983 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.511 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 24' ' ' ALA . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.419 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 64' ' ' VAL . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 76' ' ' ILE . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.925 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 72' ' ' LEU . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 77' ' ' LEU . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.507 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.472 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD11 HD13 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG2' HG23 ' A' ' 21' ' ' VAL . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.617 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.506 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.495 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 72' ' ' LEU . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.472 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.643 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 17' ' ' LYS . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.422 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 80' ' ' LYS . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 69' ' ' ALA . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 32' ' ' TYR . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.328 0.585 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 24' ' ' ALA . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 38' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 45' ' ' LYS . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.49 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.78 HG12 ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.78 ' OE1' HG12 ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HE3' HG11 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 76' ' ' ILE . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 42' ' ' LEU . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.415 HD13 ' OE1' ' A' ' 71' ' ' GLN . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.636 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.804 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.636 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.448 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 32' ' ' TYR . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 57' ' ' VAL . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.528 ' CD1' ' OE1' ' A' ' 68' ' ' GLU . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.7 ' CE2' HD11 ' A' ' 79' ' ' ILE . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 75' ' ' TRP . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.855 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.668 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 77' ' ' LEU . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.575 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.48 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 65' ' ' THR . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.855 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.741 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.566 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 33' ' ' ALA . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.741 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.491 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 24' ' ' ALA . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 38' ' ' ALA . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.581 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 64' ' ' VAL . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 77' ' ' LEU . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.557 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 25' ' ' TYR . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 74' ' ' GLN . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.819 HG21 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.359 0.599 . . . . 0.0 109.485 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.65 HD13 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.424 ' CE ' HD21 ' A' ' 16' ' ' LEU . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.788 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.908 HD12 HG21 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB2' HD13 ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ALA . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.677 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.986 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.986 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.616 HD21 ' HE2' ' A' ' 32' ' ' TYR . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' ALA . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.426 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.65 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.651 ' CE2' HD11 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.491 HD21 ' NE2' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.949 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG23 ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 77' ' ' LEU . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 38' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HE2' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 54' ' ' TRP . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.485 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.491 ' NE2' HD21 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 68' ' ' GLU . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.85 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' LEU . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 77' ' ' LEU . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 75' ' ' TRP . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 10' ' ' CYS . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.518 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB1' ' OXT' ' A' ' 80' ' ' LYS . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.643 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 42' ' ' LEU . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.713 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.661 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 8' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 69' ' ' ALA . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 72' ' ' LEU . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.554 ' CG2' HD13 ' A' ' 16' ' ' LEU . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.487 ' OXT' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 109.362 -0.606 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.661 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.846 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.846 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.716 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 46' ' ' ILE . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 43' ' ' ALA . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.661 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 77' ' ' LEU . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.658 HG21 HD22 ' A' ' 16' ' ' LEU . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.667 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.679 ' HB2' HD23 ' A' ' 16' ' ' LEU . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 39' ' ' VAL . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 38' ' ' ALA . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 43' ' ' ALA . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' N ' ' CD ' ' A' ' 62' ' ' GLN . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.597 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 69' ' ' ALA . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HD12 ' A' ' 79' ' ' ILE . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 77' ' ' LEU . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.815 HG21 HD22 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.871 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.556 HD22 HD13 ' A' ' 79' ' ' ILE . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.871 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 42' ' ' LEU . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.438 HG11 ' OH ' ' A' ' 32' ' ' TYR . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.837 ' OE1' HG12 ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.759 HD23 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.759 ' CE3' HD23 ' A' ' 72' ' ' LEU . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 72' ' ' LEU . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 16' ' ' LEU . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.69 HD21 ' OE1' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.547 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.887 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 15' ' ' ASP . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 24' ' ' ALA . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 77' ' ' LEU . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.409 ' O ' ' CD1' ' A' ' 54' ' ' TRP . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.403 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 64' ' ' VAL . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.69 ' OE1' HD21 ' A' ' 4' ' ' LEU . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' GLN . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 42' ' ' LEU . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 16' ' ' LEU . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.778 HD21 ' OE1' ' A' ' 71' ' ' GLN . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.613 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 79' ' ' ILE . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HG2' HG23 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 24' ' ' ALA . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.682 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.996 ' CE2' HD21 ' A' ' 42' ' ' LEU . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 59' ' ' MET . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.511 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.511 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.415 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.404 ' OE1' ' HA ' ' A' ' 62' ' ' GLN . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.778 ' OE1' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 29' ' ' ALA . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 16' ' ' LEU . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.332 0.587 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -157.07 -41.75 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -0.912 . . . . 0.0 109.418 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.442 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -68.83 -14.22 62.89 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.313 -0.867 . . . . 0.0 109.592 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mt -83.97 -16.51 43.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -99.67 3.5 45.15 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.291 -0.881 . . . . 0.0 109.625 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.43 -60.46 1.81 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.987 . . . . 0.0 109.76 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' A' ' 8' ' ' LYS . 7.2 pt20 -51.49 -34.6 36.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.811 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.549 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -74.12 -54.2 8.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.336 -0.853 . . . . 0.0 109.272 -179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 118.93 24.73 2.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.576 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 35.4 m -79.69 -30.97 41.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -1.158 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -15.73 62.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 109.724 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.0 60.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.4 m -123.3 33.05 5.47 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.387 -0.821 . . . . 0.0 109.277 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CE1' ' HD2' ' A' ' 23' ' ' PRO . 8.2 m-70 -148.83 -176.4 5.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.031 . . . . 0.0 109.87 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.861 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.63 148.74 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.5 -0.75 . . . . 0.0 109.199 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.593 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 30.8 mt -50.39 -75.68 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.172 -0.955 . . . . 0.0 109.21 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -120.56 40.91 3.38 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.426 -0.796 . . . . 0.0 109.284 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.861 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -118.39 67.58 0.77 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.14 110.7 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.353 -0.842 . . . . 0.0 109.77 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -128.96 -95.72 0.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 0.0 109.062 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 78.0 t -94.27 -72.81 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.131 -0.981 . . . . 0.0 108.887 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -178.07 43.08 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.587 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.9 Cg_endo -78.93 119.74 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.183 . . . . 0.0 110.496 -179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -47.39 141.06 5.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 0.0 109.144 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -49.24 -49.29 43.92 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.217 -0.927 . . . . 0.0 109.754 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -46.94 -54.11 10.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -0.888 . . . . 0.0 109.84 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -59.79 -35.14 74.06 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.244 -0.91 . . . . 0.0 110.169 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.74 -46.47 93.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.102 -0.999 . . . . 0.0 109.845 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.625 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -63.51 -38.02 89.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.249 -0.907 . . . . 0.0 109.941 -179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.6 tptt -65.65 -28.56 69.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 0.0 109.639 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -16.76 63.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.18 -0.95 . . . . 0.0 109.798 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.713 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 48.1 m-85 -133.89 165.36 25.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.162 -0.961 . . . . 0.0 109.047 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.713 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 163.59 109.91 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.145 -0.972 . . . . 0.0 109.71 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.51 -11.8 70.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -58.64 145.94 38.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -1.096 . . . . 0.0 109.523 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.429 ' H ' ' CD ' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -87.32 -1.17 57.72 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.91 . . . . 0.0 109.809 -179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.453 ' O ' ' CB ' ' A' ' 41' ' ' TYR . 1.1 m-20 -139.04 38.61 2.13 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.266 -0.896 . . . . 0.0 109.515 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -74.6 -24.68 58.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.269 -0.894 . . . . 0.0 109.547 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.407 HG11 ' HD3' ' A' ' 70' ' ' LYS . 6.3 t -80.55 -58.5 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -0.948 . . . . 0.0 109.37 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -61.47 -37.8 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.289 -0.882 . . . . 0.0 109.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' CB ' ' O ' ' A' ' 37' ' ' ASP . 53.8 t80 -64.36 -58.7 5.74 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD21 ' CE2' ' A' ' 32' ' ' TYR . 33.1 mt -56.78 -70.87 0.11 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.232 -0.918 . . . . 0.0 109.355 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.13 -26.91 0.18 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.436 -0.79 . . . . 0.0 109.454 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -62.85 -55.68 25.42 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mptt -70.38 -6.87 38.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -1.108 . . . . 0.0 109.241 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.2 mt -84.94 -43.04 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.31 -0.868 . . . . 0.0 109.99 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' HE3' ' OD2' ' A' ' 66' ' ' ASP . 0.7 OUTLIER -88.46 0.75 55.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.169 -0.957 . . . . 0.0 109.998 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.0 mttm -129.79 -59.97 1.05 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.052 -1.03 . . . . 0.0 109.711 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 113.71 -153.09 17.79 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 125.88 -160.16 20.33 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.423 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 0.3 OUTLIER 179.5 167.65 1.11 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.109 -1.23 . . . . 0.0 109.757 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 124.52 -12.94 7.84 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -100.63 -21.06 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.299 -1.118 . . . . 0.0 109.481 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.587 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 97.1 m95 -123.1 8.34 9.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 109.729 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 136.94 -150.5 20.62 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 1.1 m -104.15 -11.59 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -1.176 . . . . 0.0 109.76 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 51' ' ' SER . 26.9 t -57.16 111.35 3.27 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 109.281 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.2 Cg_endo -77.59 105.76 2.09 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.53 2.154 . . . . 0.0 110.932 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.479 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.5 ttt -71.71 142.52 86.06 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.326 -0.859 . . . . 0.0 109.182 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.01 164.16 22.6 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.632 2.221 . . . . 0.0 110.762 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.95 153.92 29.36 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.711 2.274 . . . . 0.0 110.429 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -121.46 159.62 25.86 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.683 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -104.09 78.07 1.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.276 -0.89 . . . . 0.0 109.338 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.94 152.96 33.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.213 -0.93 . . . . 0.0 109.516 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -82.0 164.88 21.15 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.357 -0.839 . . . . 0.0 108.912 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.438 ' OD2' ' HE3' ' A' ' 47' ' ' LYS . 7.1 m-20 -68.86 -15.88 63.62 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.099 -1.001 . . . . 0.0 109.46 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.26 -60.03 2.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.28 -0.887 . . . . 0.0 109.218 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.571 ' OE2' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -62.13 -34.14 75.81 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.164 179.759 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.12 -39.04 92.51 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.292 -0.88 . . . . 0.0 108.934 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD3' HG11 ' A' ' 39' ' ' VAL . 1.3 mttm -65.35 -32.05 73.5 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.321 -0.862 . . . . 0.0 109.105 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.0 OUTLIER -76.02 -22.37 55.83 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.318 -0.864 . . . . 0.0 109.518 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.658 ' O ' HD12 ' A' ' 76' ' ' ILE . 20.8 mt -80.62 -28.97 36.86 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 109.251 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -83.68 -37.68 22.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.114 -0.992 . . . . 0.0 108.636 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -73.38 -35.81 65.97 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.343 -0.848 . . . . 0.0 108.726 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.491 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 15.5 t90 -75.85 -43.44 45.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.475 -0.766 . . . . 0.0 109.283 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.658 HD12 ' O ' ' A' ' 72' ' ' LEU . 54.8 mt -60.12 -36.05 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.183 -0.948 . . . . 0.0 109.464 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.625 HD23 ' HA ' ' A' ' 29' ' ' ALA . 90.8 mt -70.69 -46.73 62.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 108.906 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -53.36 -22.58 7.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.0 108.922 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.46 HD13 ' CD2' ' A' ' 16' ' ' LEU . 25.2 mt -81.59 129.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.479 -0.763 . . . . 0.0 109.332 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' LYS . 5.4 ptmt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.546 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.844 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.57 ' HB2' HD23 ' A' ' 4' ' ' LEU . 6.8 m-20 . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -178.69 -40.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.934 . . . . 0.0 109.695 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -73.82 -30.35 62.66 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.163 -0.961 . . . . 0.0 110.005 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.57 HD23 ' HB2' ' A' ' 1' ' ' ASN . 0.9 OUTLIER -69.48 -29.61 67.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.164 -0.96 . . . . 0.0 109.726 -179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.61 -8.32 57.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.128 -0.982 . . . . 0.0 109.489 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.39 -56.09 3.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.492 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -72.95 -2.65 21.81 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.28 -0.887 . . . . 0.0 109.736 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 6.4 mmtt -86.59 -46.3 10.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.18 -0.95 . . . . 0.0 109.507 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.18 13.92 4.25 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.524 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 16.1 m -87.75 -36.67 17.2 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.265 -1.138 . . . . 0.0 109.362 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.49 -21.28 65.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.322 -0.861 . . . . 0.0 109.772 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.7 -31.44 11.17 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.7 m -135.75 35.61 2.89 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.512 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 27.2 m-70 -139.25 -176.43 4.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.93 -1.106 . . . . 0.0 110.124 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.686 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 161.07 136.12 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.1 mt -53.0 -67.15 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.111 -0.993 . . . . 0.0 109.683 -179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.8 41.95 3.42 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.323 -0.861 . . . . 0.0 109.705 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -138.67 49.93 1.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.042 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 3.5 mtmp? -43.23 136.64 2.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.496 -0.752 . . . . 0.0 110.117 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.39 -56.46 0.53 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.75 -66.39 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -87.31 -171.6 47.43 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.86 139.65 15.67 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.595 2.197 . . . . 0.0 110.464 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.888 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -69.46 149.41 48.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.0 109.122 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.518 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 12.8 m-85 -62.96 -40.2 96.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.226 -0.921 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.04 -53.44 53.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.183 -0.948 . . . . 0.0 109.83 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -56.6 -33.9 66.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.173 -0.954 . . . . 0.0 109.676 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.888 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.5 t -65.37 -56.79 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.193 -0.942 . . . . 0.0 109.412 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -46.42 -39.33 10.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.9 . . . . 0.0 109.084 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 tptt -57.43 -57.26 13.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.263 -0.898 . . . . 0.0 109.258 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 mmmt -47.15 -26.93 1.25 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 108.899 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 78.3 m-85 -109.94 -132.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 0.0 109.093 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.5 107.67 0.07 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.085 . . . . 0.0 109.359 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.48 -12.11 68.06 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.505 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -79.44 116.02 19.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.363 -1.08 . . . . 0.0 109.416 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -58.77 -36.76 74.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 0.0 109.726 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.27 39.08 1.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.184 -0.948 . . . . 0.0 109.83 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.734 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -85.23 -29.27 24.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.289 -0.882 . . . . 0.0 109.266 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 47.1 t -77.1 -40.84 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 0.0 109.0 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -75.76 -53.42 8.53 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.135 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.558 ' CZ ' ' HE2' ' A' ' 45' ' ' LYS . 26.4 t80 -53.65 -41.25 66.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.39 -0.819 . . . . 0.0 109.526 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' O ' ' A' ' 38' ' ' ALA . 34.6 mt -65.14 -70.09 0.25 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -40.27 -29.34 0.08 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.637 -0.664 . . . . 0.0 109.32 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . -65.69 -62.96 4.36 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.79 ' NZ ' HG11 ' A' ' 53' ' ' VAL . 3.7 mtmt -59.65 -15.33 18.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.362 -1.081 . . . . 0.0 109.41 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.479 HG12 ' CMA' ' A' ' 81' ' ' HEC . 5.1 mt -77.35 -40.99 29.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.455 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -102.0 6.91 41.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.156 -0.965 . . . . 0.0 109.843 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HB2' ' O ' ' A' ' 44' ' ' GLY . 0.0 OUTLIER -114.05 -25.91 8.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.117 -0.99 . . . . 0.0 109.503 179.934 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.84 -166.87 26.47 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.495 ' HA3' ' CGD' ' A' ' 81' ' ' HEC . . . -154.84 174.95 33.06 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.44 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 7.9 p 169.49 56.5 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.262 -1.14 . . . . 0.0 109.536 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 148.36 -28.39 1.36 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.79 HG11 ' NZ ' ' A' ' 45' ' ' LYS . 33.7 t -65.1 -36.4 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -1.169 . . . . 0.0 109.492 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -117.69 -7.05 11.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.38 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 159.24 -178.08 35.53 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.464 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.4 p -71.37 -28.69 64.22 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -1.099 . . . . 0.0 109.481 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 91.9 t -50.01 106.98 0.7 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 56' ' ' SER . 35.4 Cg_endo -77.61 104.14 1.83 Allowed 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.439 2.093 . . . . 0.0 110.407 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.413 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 10.7 ttt -69.45 139.39 89.3 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.288 -0.882 . . . . 0.0 109.159 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.61 162.11 24.65 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.48 2.12 . . . . 0.0 110.281 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.24 130.12 9.96 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.593 2.196 . . . . 0.0 110.067 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.442 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 64.9 mm-40 -93.65 162.45 13.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.088 -1.008 . . . . 0.0 109.573 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -97.41 90.46 5.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.293 -0.88 . . . . 0.0 109.491 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -141.65 -177.93 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 0.0 109.415 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.59 -178.96 4.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.385 -0.822 . . . . 0.0 108.87 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 2.2 m-20 -69.29 -15.87 63.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.162 -0.961 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.18 -59.05 2.92 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.311 -0.868 . . . . 0.0 109.056 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -61.28 -38.46 86.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.295 -0.878 . . . . 0.0 109.485 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.13 -28.6 67.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.897 . . . . 0.0 109.521 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.0 OUTLIER -71.62 -45.49 61.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.171 -0.956 . . . . 0.0 109.864 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -74.29 -22.72 59.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.172 -0.955 . . . . 0.0 109.512 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.433 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 37.8 mt -80.12 -24.3 40.6 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.241 -0.912 . . . . 0.0 109.011 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.64 -39.4 16.14 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.293 -0.88 . . . . 0.0 108.71 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -74.56 -31.19 62.01 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.503 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 13.5 t90 -75.66 -48.16 23.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.514 -0.741 . . . . 0.0 109.241 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.518 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 73.7 mt -63.93 -38.73 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.046 -1.034 . . . . 0.0 109.632 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.655 HD11 ' CD1' ' A' ' 42' ' ' LEU . 63.3 mt -66.0 -45.73 80.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.115 -0.991 . . . . 0.0 109.678 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -58.45 -21.15 50.25 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.318 -0.864 . . . . 0.0 109.623 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.415 HD13 HD22 ' A' ' 16' ' ' LEU . 38.1 mt -81.29 105.62 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.231 -0.918 . . . . 0.0 109.43 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.4 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.965 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.7 p30 . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -148.06 99.38 3.06 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.237 -0.914 . . . . 0.0 109.407 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 173.06 -42.62 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.233 -0.917 . . . . 0.0 109.097 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.511 HD12 ' OE1' ' A' ' 71' ' ' GLN . 60.8 mt -81.15 -0.28 39.58 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.4 -0.812 . . . . 0.0 109.373 179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.31 -29.85 5.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.205 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -83.8 -61.23 1.88 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.89 . . . . 0.0 109.491 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.412 ' O ' ' C ' ' A' ' 8' ' ' LYS . 33.5 mt-30 -62.35 -49.44 75.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.131 -0.981 . . . . 0.0 109.564 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -43.67 -68.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.33 49.41 0.11 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.486 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 36.5 m -105.82 -44.09 4.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.325 -1.103 . . . . 0.0 109.52 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.73 -13.8 11.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.98 -179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.34 -36.16 20.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 109.118 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 5.7 m -121.41 -2.82 9.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.511 -0.743 . . . . 0.0 109.238 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.522 ' HB3' ' CE2' ' A' ' 25' ' ' TYR . 26.7 m-70 -108.39 -169.38 1.49 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.286 -0.884 . . . . 0.0 109.804 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.808 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 0.5 OUTLIER 162.69 135.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.544 -0.723 . . . . 0.0 109.122 -179.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.856 ' CD2' HD13 ' A' ' 79' ' ' ILE . 52.9 mt -40.58 -69.09 0.14 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.8 . . . . 0.0 109.844 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.93 45.36 2.81 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.265 -0.897 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.808 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -126.73 87.92 2.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.868 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.3 mtmm -47.67 132.95 14.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.257 -0.902 . . . . 0.0 109.002 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 21' ' ' VAL . 1.1 mttt -151.75 -161.28 1.29 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.9 . . . . 0.0 109.23 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' LYS . 75.8 t -43.17 -29.92 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.865 . . . . 0.0 108.673 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.525 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -120.6 173.54 15.42 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 108.963 -1.655 . . . . 0.0 108.963 179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.66 125.3 7.43 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.534 2.156 . . . . 0.0 110.418 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.87 144.77 1.08 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 109.433 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.522 ' CE2' ' HB3' ' A' ' 14' ' ' HIS . 11.7 m-85 -58.35 -54.87 42.14 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.328 -0.857 . . . . 0.0 109.371 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -44.6 -28.76 0.63 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.852 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -77.7 -49.08 15.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.163 -0.96 . . . . 0.0 109.93 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.544 ' HA ' ' CZ2' ' A' ' 54' ' ' TRP . 70.4 t -55.48 -47.42 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.235 -0.916 . . . . 0.0 109.323 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.71 ' HB1' HD23 ' A' ' 77' ' ' LEU . . . -66.12 -31.86 72.97 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.278 -0.889 . . . . 0.0 109.129 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.24 -35.48 80.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 8.7 mttm -62.01 -31.69 72.1 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 0.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 16.0 m-85 -96.61 -115.57 0.13 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 76.67 106.97 0.08 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.804 -1.185 . . . . 0.0 109.354 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.72 -13.97 63.43 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 -179.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.54 113.0 12.46 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.359 -1.083 . . . . 0.0 109.274 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.5 mttm -68.42 -6.88 27.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.317 -0.864 . . . . 0.0 109.887 -179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.0 34.04 5.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 109.602 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.491 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -83.38 -25.13 31.64 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.145 -0.972 . . . . 0.0 109.512 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 54.0 t -74.39 -45.31 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.257 -0.902 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -74.37 -51.17 15.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.228 -0.92 . . . . 0.0 109.535 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -50.83 -53.24 33.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.407 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 38' ' ' ALA . 6.5 mt -56.62 -54.96 40.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.579 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -46.99 -32.36 3.85 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.445 -0.785 . . . . 0.0 110.01 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.85 -57.46 7.1 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -5.01 21.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -1.155 . . . . 0.0 109.64 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 42' ' ' LEU . 66.3 mt -91.47 -32.53 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.271 -0.893 . . . . 0.0 109.112 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.05 -18.47 24.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 0.0 109.574 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.53 -12.48 14.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.707 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.07 -132.02 45.67 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 102.43 -165.11 16.69 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 57' ' ' VAL . 29.6 t -173.53 163.82 4.43 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.35 -1.089 . . . . 0.0 109.542 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 123.7 -15.48 7.98 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 53' ' ' VAL . 53.2 t -94.0 -13.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -1.101 . . . . 0.0 109.429 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.544 ' CZ2' ' HA ' ' A' ' 28' ' ' VAL . 93.0 m95 -132.93 6.42 3.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.586 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 147.07 -134.56 5.28 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.57 -5.98 7.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.295 -1.121 . . . . 0.0 109.616 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' SER . 3.0 m -57.72 117.73 21.08 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.22 -0.925 . . . . 0.0 109.416 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.46 110.44 2.97 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.46 2.107 . . . . 0.0 110.351 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.498 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 15.0 ttt -86.03 141.07 35.09 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.498 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -79.32 155.65 25.29 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.623 2.215 . . . . 0.0 110.598 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.33 141.38 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.605 2.203 . . . . 0.0 110.267 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.406 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 45.1 mm-40 -104.22 164.06 11.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -104.57 57.22 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.192 -0.942 . . . . 0.0 109.371 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.36 156.26 13.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.911 . . . . 0.0 109.584 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.32 -179.14 5.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.86 . . . . 0.0 109.527 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -67.58 -41.25 84.44 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.24 -0.913 . . . . 0.0 109.399 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.474 ' O ' ' HB2' ' A' ' 70' ' ' LYS . . . -59.42 -45.62 91.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.298 -0.876 . . . . 0.0 109.438 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -61.6 -51.25 69.31 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.255 -0.903 . . . . 0.0 109.594 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -61.05 -22.33 64.49 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 108.969 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 2.3 mttm -70.23 -43.64 70.19 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.372 -0.83 . . . . 0.0 109.584 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' OE1' HD12 ' A' ' 4' ' ' LEU . 3.0 tm0? -71.76 -23.2 61.55 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.216 -0.927 . . . . 0.0 109.622 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 5.1 mt -79.97 -27.37 39.7 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.043 -1.036 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.8 -28.93 22.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.921 . . . . 0.0 108.959 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 3.4 pt20 -79.94 -37.13 35.19 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.812 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 12.7 t90 -77.67 -41.16 39.12 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 49.4 mt -65.99 -36.01 76.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.203 -0.935 . . . . 0.0 109.377 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.71 HD23 ' HB1' ' A' ' 29' ' ' ALA . 48.6 mt -75.54 -40.41 56.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.5 t -82.83 -1.32 51.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 0.0 109.611 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.856 HD13 ' CD2' ' A' ' 16' ' ' LEU . 0.2 OUTLIER -65.57 152.63 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.07 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.0 ttpm? . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.473 179.67 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.932 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.546 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 1.3 mp0 -61.14 176.06 0.47 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.154 -0.966 . . . . 0.0 109.292 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 82.73 -43.29 0.12 Allowed 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.567 -0.708 . . . . 0.0 110.152 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.0 mt -71.51 -35.9 70.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 0.0 109.588 -179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.16 13.44 34.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.239 -0.913 . . . . 0.0 109.653 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -96.71 -9.16 29.63 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.171 -0.956 . . . . 0.0 109.645 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.438 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 2.9 pt20 -111.82 -33.98 6.15 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.242 -0.911 . . . . 0.0 109.839 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.438 ' HE3' ' OE1' ' A' ' 7' ' ' GLN . 0.1 OUTLIER -63.25 -24.83 68.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.57 30.51 13.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.641 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.5 m -77.8 -33.08 52.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.148 -1.207 . . . . 0.0 109.382 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.6 mmt -76.91 -13.73 59.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.332 -0.855 . . . . 0.0 109.617 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.55 -30.88 22.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.196 -0.94 . . . . 0.0 109.377 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.513 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 52.0 m -121.99 -44.3 2.3 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.409 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.583 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.6 m-70 -69.87 -171.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.328 -0.858 . . . . 0.0 109.827 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.616 ' OD2' ' HB3' ' A' ' 18' ' ' ALA . 0.1 OUTLIER 169.98 132.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.843 . . . . 0.0 109.141 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.682 HD11 HD13 ' A' ' 79' ' ' ILE . 3.7 mm? -42.65 -70.05 0.12 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.344 -0.848 . . . . 0.0 109.585 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 32.3 tttt -127.88 45.08 2.81 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.282 -0.886 . . . . 0.0 109.743 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.616 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -153.7 59.46 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.322 -0.862 . . . . 0.0 109.274 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.92 101.79 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.461 -0.774 . . . . 0.0 109.805 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 tptt -86.45 -68.6 0.73 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.287 -0.883 . . . . 0.0 108.63 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.513 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 42.3 t -102.21 -49.59 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.653 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -99.39 -172.57 30.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.429 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.5 Cg_endo -77.29 148.15 26.65 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.513 2.142 . . . . 0.0 110.144 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -68.58 136.76 53.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.138 -0.976 . . . . 0.0 109.469 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD1' HG12 ' A' ' 76' ' ' ILE . 50.9 m-85 -48.96 -42.5 37.73 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.189 -0.944 . . . . 0.0 109.398 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.54 ' HB2' ' HG3' ' A' ' 80' ' ' LYS . . . -53.51 -47.77 69.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.433 -0.792 . . . . 0.0 110.002 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.6 -48.68 80.7 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.109 -0.995 . . . . 0.0 109.726 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.1 t -54.54 -38.38 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 0.0 109.776 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.769 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -61.25 -49.78 75.7 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.231 -0.918 . . . . 0.0 109.642 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -61.53 -25.91 67.59 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.319 -0.863 . . . . 0.0 109.895 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' HB3' ' CE1' ' A' ' 32' ' ' TYR . 2.6 mtpp -75.83 -23.14 55.74 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.191 -0.943 . . . . 0.0 110.103 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 8.1 m-85 -127.03 133.82 50.43 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.056 -1.028 . . . . 0.0 109.823 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 170.47 -32.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.364 -0.835 . . . . 0.0 109.213 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -82.34 7.21 65.05 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.8 mtp180 -118.27 141.56 48.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 0.0 109.409 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.81 11.68 8.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -130.74 37.07 3.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -76.78 -23.11 52.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.333 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.6 t -77.51 -52.01 17.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 109.443 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -64.55 -48.51 74.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.503 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -58.54 -55.5 34.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.308 -0.87 . . . . 0.0 109.636 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.842 HD12 HD11 ' A' ' 77' ' ' LEU . 16.6 mt -49.51 -69.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.332 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.17 -28.27 0.28 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.438 -0.788 . . . . 0.0 109.407 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -63.25 -53.93 36.15 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.232 -1.547 . . . . 0.0 109.232 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 0.9 OUTLIER -76.54 -2.51 32.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -1.143 . . . . 0.0 109.465 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 43' ' ' ALA . 21.5 mt -81.33 -51.65 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.204 -0.935 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -74.24 -22.06 59.51 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.186 -0.946 . . . . 0.0 109.68 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 0.0 OUTLIER -107.67 -59.92 1.77 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.979 . . . . 0.0 109.659 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 45' ' ' LYS . . . 94.99 -145.37 17.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 129.59 -167.93 21.28 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.436 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -157.74 132.28 8.43 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.317 -1.107 . . . . 0.0 109.363 179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 155.64 -25.89 0.58 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -86.37 -25.43 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.331 -1.099 . . . . 0.0 109.494 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.486 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 98.5 m95 -115.92 8.17 14.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.222 -0.924 . . . . 0.0 109.533 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.81 -118.55 2.92 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.45 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.3 OUTLIER -122.37 -18.45 6.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -1.152 . . . . 0.0 109.602 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.622 ' O ' HG23 ' A' ' 57' ' ' VAL . 24.3 m -46.17 104.6 0.41 Allowed Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.243 -0.911 . . . . 0.0 109.432 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.1 Cg_endo -79.38 133.09 10.51 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.547 2.164 . . . . 0.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 5.2 ttt -111.19 137.02 20.86 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 108.86 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 35.6 Cg_endo -79.89 153.29 22.43 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.633 2.222 . . . . 0.0 110.697 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 34.8 Cg_endo -77.71 122.46 5.93 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.624 2.216 . . . . 0.0 110.149 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.824 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 48.1 mm-40 -84.47 164.38 18.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.249 -0.907 . . . . 0.0 109.7 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -96.32 55.15 1.46 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.135 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.451 HG12 ' OE1' ' A' ' 68' ' ' GLU . 27.8 m -100.32 157.13 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.303 -0.873 . . . . 0.0 109.793 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 34.0 p -90.32 167.49 12.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.3 OUTLIER -67.34 -14.1 62.61 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.047 -1.033 . . . . 0.0 109.637 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.7 -63.77 1.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.179 -0.95 . . . . 0.0 109.149 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.451 ' OE1' HG12 ' A' ' 64' ' ' VAL . 12.1 pt-20 -60.67 -33.21 72.48 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.85 -34.22 76.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.16 -0.963 . . . . 0.0 109.427 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -67.32 -42.67 83.23 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.3 -0.875 . . . . 0.0 109.656 -179.854 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.552 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.2 OUTLIER -72.48 -23.06 60.98 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.225 -0.922 . . . . 0.0 109.766 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' ILE . 23.2 mt -79.47 -29.27 41.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.28 -0.887 . . . . 0.0 109.36 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.401 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -81.38 -41.37 22.06 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.207 -0.933 . . . . 0.0 108.779 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.71 -35.06 70.08 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.552 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 4.5 t90 -70.61 -46.28 63.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.382 -0.824 . . . . 0.0 108.9 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' LEU . 30.7 mt -60.0 -42.38 89.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.147 -0.971 . . . . 0.0 109.109 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.842 HD11 HD12 ' A' ' 42' ' ' LEU . 95.9 mt -68.4 -31.9 71.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.364 -0.835 . . . . 0.0 109.171 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.97 -19.28 60.17 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.246 -0.908 . . . . 0.0 109.012 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.682 HD13 HD11 ' A' ' 16' ' ' LEU . 3.7 mt -71.42 137.38 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 108.949 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 26' ' ' ALA . 17.6 mmtt . . . . . 0 N--CA 1.489 1.499 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.493 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.824 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.4 p30 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.46 ' O ' ' HG2' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -96.95 119.12 34.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.315 -0.865 . . . . 0.0 109.598 -179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 2' ' ' GLU . 0.5 OUTLIER 168.65 -75.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.831 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.485 ' HG ' ' N ' ' A' ' 5' ' ' ALA . 1.7 pp -47.65 -32.41 5.62 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.392 -0.818 . . . . 0.0 109.635 -179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.485 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -67.99 -42.65 80.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.125 -0.985 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' GLN . 49.3 mtpt -56.34 -43.23 78.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.303 -0.873 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -45.52 -46.92 14.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.391 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.5 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -68.05 -37.73 81.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.355 -0.84 . . . . 0.0 109.291 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.09 53.07 0.97 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 25' ' ' TYR . 34.7 m -91.63 -41.9 10.49 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.173 -1.192 . . . . 0.0 109.331 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 14' ' ' HIS . 0.0 OUTLIER -56.52 -17.25 7.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.803 -179.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -47.56 -26.91 1.6 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -0.906 . . . . 0.0 109.388 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 58.4 m -128.86 -24.42 2.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 110.137 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.497 ' CD2' ' N ' ' A' ' 14' ' ' HIS . 5.1 m-70 -107.1 162.2 14.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.021 -1.049 . . . . 0.0 109.572 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.67 ' HB3' ' HB3' ' A' ' 18' ' ' ALA . 7.2 t70 -160.44 23.27 0.15 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.33 -0.856 . . . . 0.0 109.754 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.752 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.0 mt 81.36 -59.32 0.24 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.143 0.497 . . . . 0.0 110.394 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -136.27 45.64 2.34 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.302 -0.874 . . . . 0.0 109.943 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.67 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -141.11 65.33 1.4 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.155 -0.966 . . . . 0.0 109.174 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.1 mtmp? -51.17 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 0.0 109.805 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -113.16 -89.37 0.53 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.899 . . . . 0.0 109.133 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 97.4 t -83.63 -38.86 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.013 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.761 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -120.29 -177.26 15.94 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.428 ' HD2' ' CE1' ' A' ' 14' ' ' HIS . 35.0 Cg_endo -78.26 145.51 21.57 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.705 2.27 . . . . 0.0 110.467 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.752 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -64.6 142.66 58.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.225 -0.922 . . . . 0.0 109.403 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 5.0 m-85 -63.74 -40.32 96.43 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.895 . . . . 0.0 109.633 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.02 -48.59 81.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -60.0 -41.03 91.18 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.288 -0.882 . . . . 0.0 109.765 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 24' ' ' ALA . 73.4 t -54.74 -44.76 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.17 -0.956 . . . . 0.0 109.305 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -58.24 -51.9 67.81 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.269 -0.894 . . . . 0.0 109.747 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.96 -8.28 43.15 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.242 -0.911 . . . . 0.0 109.798 -179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.54 ' HG2' ' CZ2' ' A' ' 54' ' ' TRP . 4.7 tptp -94.91 -24.81 16.82 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.22 -0.925 . . . . 0.0 109.837 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -119.89 5.77 10.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.078 -1.014 . . . . 0.0 109.747 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.17 -27.47 68.03 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.179 -0.951 . . . . 0.0 109.45 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -67.0 -8.07 47.13 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.458 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.4 ttt180 -89.94 167.83 12.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.129 -1.218 . . . . 0.0 109.517 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.18 -30.84 10.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.306 -0.872 . . . . 0.0 109.502 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 37.1 p30 -121.06 43.81 2.69 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.252 -0.905 . . . . 0.0 109.506 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -67.07 -10.8 53.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.259 -0.9 . . . . 0.0 109.51 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.5 t -70.45 -59.89 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.27 -50.85 58.81 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.22 -0.925 . . . . 0.0 109.287 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -49.07 -44.33 41.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 0.0 109.135 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 38' ' ' ALA . 19.7 mt -56.67 -50.26 72.65 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.25 -0.906 . . . . 0.0 109.0 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -50.84 -36.21 36.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.473 -0.767 . . . . 0.0 109.308 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -67.62 -41.55 89.51 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.4 tttt -88.86 7.12 35.89 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.206 -1.173 . . . . 0.0 109.415 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.497 HG12 ' CMA' ' A' ' 81' ' ' HEC . 26.2 mt -102.2 -60.03 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.015 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.67 -15.2 63.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.248 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.4 -30.39 13.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.395 -0.816 . . . . 0.0 109.44 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.5 -159.91 53.0 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 126.79 -158.1 20.7 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.482 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 27.8 p 179.81 150.76 0.37 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -1.214 . . . . 0.0 109.566 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.93 -30.45 1.36 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.3 t -91.29 -22.71 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -1.135 . . . . 0.0 109.385 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.54 ' CZ2' ' HG2' ' A' ' 31' ' ' LYS . 97.3 m95 -123.88 17.27 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.382 -0.824 . . . . 0.0 109.395 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.5 -171.8 18.2 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -92.25 -13.88 29.76 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -1.155 . . . . 0.0 109.421 -179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.517 ' HB ' ' CMD' ' A' ' 81' ' ' HEC . 18.8 t -43.66 107.61 0.6 Allowed Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.294 -0.879 . . . . 0.0 109.197 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.63 97.3 1.13 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.477 2.118 . . . . 0.0 110.635 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.1 ttt -74.05 134.27 77.84 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 0.0 109.047 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 36.3 Cg_endo -79.57 154.81 24.14 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.537 2.158 . . . . 0.0 110.461 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -78.17 136.48 14.51 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.704 2.269 . . . . 0.0 110.06 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.812 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 17.6 mm-40 -100.46 -162.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.193 -0.942 . . . . 0.0 109.624 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -117.69 65.84 0.74 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -0.869 . . . . 0.0 109.247 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' CG1' ' HD3' ' A' ' 8' ' ' LYS . 13.7 m -111.54 151.88 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.352 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.61 -175.37 3.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.906 . . . . 0.0 109.227 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -67.79 -41.01 83.87 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.071 -1.018 . . . . 0.0 109.501 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -63.34 -41.17 98.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -66.45 -44.89 81.56 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.214 -0.929 . . . . 0.0 109.96 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.44 -26.83 68.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.928 . . . . 0.0 109.168 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -67.43 -50.29 60.03 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.277 -0.889 . . . . 0.0 109.684 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.5 tm0? -70.44 -19.49 62.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.22 -0.925 . . . . 0.0 109.392 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.526 ' O ' HD12 ' A' ' 76' ' ' ILE . 25.4 mt -81.83 -31.26 31.76 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.074 -1.017 . . . . 0.0 109.524 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -82.05 -36.33 27.81 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.16 -0.962 . . . . 0.0 108.857 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -73.38 -37.55 65.97 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.251 -0.905 . . . . 0.0 108.717 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.584 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -73.11 -43.52 61.58 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.598 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.526 HD12 ' O ' ' A' ' 72' ' ' LEU . 60.5 mt -67.75 -30.93 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.12 -0.987 . . . . 0.0 110.075 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 29' ' ' ALA . 43.9 mt -76.26 -29.23 57.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.038 -1.039 . . . . 0.0 109.556 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 80' ' ' LYS . 20.4 m -83.46 -26.09 30.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.584 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 6.8 mt -47.85 100.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.218 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 78' ' ' SER . 13.0 tptm . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.094 -0.955 . . . . 0.0 109.466 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.812 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.3 p30 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -176.41 -44.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.312 -0.867 . . . . 0.0 109.682 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -36.56 76.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 110.033 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -75.11 -20.21 59.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.115 -0.99 . . . . 0.0 109.697 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.457 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -102.3 3.3 37.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.511 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -88.92 -73.75 0.49 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.253 -0.904 . . . . 0.0 109.302 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.13 -10.05 46.19 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.246 -0.909 . . . . 0.0 109.566 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt -63.05 -44.44 95.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.219 -0.926 . . . . 0.0 109.343 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 128.23 -18.17 5.85 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.549 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 5.3 m -62.8 -33.83 76.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.321 -1.105 . . . . 0.0 109.351 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -15.41 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.412 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' O ' ' HD2' ' A' ' 20' ' ' LYS . . . -62.2 -29.53 70.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.461 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.436 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 22.6 m -128.89 41.55 3.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.384 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' ' O ' ' A' ' 13' ' ' CYS . 17.6 m-70 -148.85 -175.41 4.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -178.94 139.66 0.16 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.409 -0.807 . . . . 0.0 109.016 179.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.858 HD22 HG21 ' A' ' 79' ' ' ILE . 17.7 mt -71.56 -24.67 61.97 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 110.061 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -116.82 38.77 3.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.082 -1.011 . . . . 0.0 109.918 -179.519 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.983 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 53.86 109.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.422 -0.799 . . . . 0.0 109.893 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 18' ' ' ALA . 0.7 OUTLIER 172.91 59.71 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.1 -1.0 . . . . 0.0 109.565 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 12' ' ' ALA . 0.1 OUTLIER -171.65 -176.19 1.73 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.175 -0.953 . . . . 0.0 109.629 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.78 -60.04 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.65 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.65 178.96 5.25 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.579 ' HB3' ' CD2' ' A' ' 54' ' ' TRP . 35.5 Cg_endo -77.23 125.8 8.08 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.703 2.269 . . . . 0.0 110.354 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.983 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -49.73 153.23 1.28 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.144 -0.973 . . . . 0.0 109.506 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.511 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 13.7 m-85 -72.58 -40.25 66.75 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.296 -0.878 . . . . 0.0 109.257 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.13 -38.01 89.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.989 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -66.08 -47.79 73.08 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.349 -0.844 . . . . 0.0 109.038 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 24' ' ' ALA . 98.3 t -56.17 -34.59 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.339 -0.851 . . . . 0.0 109.182 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.483 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -69.64 -44.01 71.46 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.273 -0.892 . . . . 0.0 109.399 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.23 -21.08 64.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.11 -0.994 . . . . 0.0 109.152 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.12 -18.48 60.22 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.312 -0.868 . . . . 0.0 109.091 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.64 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 68.8 m-85 -131.71 158.7 40.45 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.415 -0.803 . . . . 0.0 108.84 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 168.61 107.93 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.855 -1.153 . . . . 0.0 109.264 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.69 -14.3 63.18 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 4.8 tpt180 -45.31 146.45 0.95 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.442 -1.034 . . . . 0.0 109.25 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -86.55 13.89 7.74 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 0.0 109.45 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -174.86 50.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.238 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.61 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -79.15 -23.2 44.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.38 -0.825 . . . . 0.0 109.284 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.3 t -74.13 -42.73 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.153 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -71.45 -47.97 52.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.847 . . . . 0.0 109.267 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -56.96 -52.73 64.06 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.194 -0.941 . . . . 0.0 109.324 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.61 HD12 ' O ' ' A' ' 38' ' ' ALA . 4.0 mt -52.88 -65.78 0.5 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.162 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 69' ' ' ALA . . . -42.58 -32.1 0.52 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.574 -0.704 . . . . 0.0 109.372 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.1 -58.01 14.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.35 -14.25 48.03 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.312 -1.11 . . . . 0.0 109.278 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -76.23 -51.7 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.33 -0.856 . . . . 0.0 108.895 179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.515 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 12.5 ttpt -89.28 14.64 10.58 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.225 -0.922 . . . . 0.0 108.986 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.474 ' O ' ' C ' ' A' ' 49' ' ' GLY . 6.5 mmtt -159.35 64.57 0.39 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.474 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . -34.94 -90.27 0.01 OUTLIER Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 -179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 79.43 -149.82 32.56 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 15.0 p -175.85 163.18 2.74 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.139 -1.212 . . . . 0.0 109.59 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 132.26 -8.4 5.36 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.5 t -116.63 -26.74 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -1.123 . . . . 0.0 109.356 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD2' ' HB3' ' A' ' 23' ' ' PRO . 87.7 m95 -125.34 17.42 8.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.304 -0.873 . . . . 0.0 109.572 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.27 -177.68 17.3 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.1 t -84.23 -25.49 29.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 0.0 109.356 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 57' ' ' VAL . 2.5 p -48.35 109.99 1.31 Allowed Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.33 -0.857 . . . . 0.0 109.12 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.2 Cg_endo -76.77 150.23 30.57 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.482 2.122 . . . . 0.0 110.843 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.532 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 3.6 ttt -112.0 143.64 29.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.84 135.66 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.513 2.142 . . . . 0.0 110.787 -179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.41 127.21 7.25 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.657 2.238 . . . . 0.0 110.029 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.8 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 22.9 mm-40 -95.43 176.06 6.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.187 -0.945 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -93.72 64.79 3.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.216 -0.927 . . . . 0.0 109.552 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 64' ' ' VAL . 4.8 m -97.77 151.82 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -0.908 . . . . 0.0 109.577 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.2 p -100.23 -172.29 2.19 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.242 -0.911 . . . . 0.0 109.105 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.23 -27.98 64.9 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.212 -0.93 . . . . 0.0 109.667 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.11 54.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.252 -0.905 . . . . 0.0 109.604 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.79 -35.87 79.43 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.183 -0.948 . . . . 0.0 109.744 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.606 ' HB1' ' HB1' ' A' ' 43' ' ' ALA . . . -74.23 -30.58 62.23 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.188 -0.945 . . . . 0.0 109.421 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.97 -35.91 67.0 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.303 -0.873 . . . . 0.0 109.811 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.511 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 4.7 tm0? -78.84 -25.83 44.1 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.194 -0.941 . . . . 0.0 109.601 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.627 ' O ' HD12 ' A' ' 76' ' ' ILE . 22.4 mt -80.37 -27.51 38.18 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.146 -0.971 . . . . 0.0 109.092 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.23 -33.28 20.77 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.168 -0.957 . . . . 0.0 108.709 179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' GLN . 1.0 OUTLIER -76.5 -34.47 58.61 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.247 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.925 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -78.22 -45.92 21.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.584 -0.698 . . . . 0.0 109.27 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 72' ' ' LEU . 57.6 mt -61.14 -43.35 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 0.0 109.429 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 77' ' ' LEU . 14.7 mt -68.21 -38.4 81.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.954 . . . . 0.0 109.154 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.8 m -66.27 -19.21 65.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.925 HD11 ' CE2' ' A' ' 75' ' ' TRP . 68.9 mt -80.01 99.13 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.2 ttmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.477 179.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.843 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.575 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 68.3 m-80 . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 121.243 0.544 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -113.1 71.6 0.75 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.868 . . . . 0.0 109.659 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 4' ' ' LEU . 25.2 pt20 -175.11 -47.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.128 -0.983 . . . . 0.0 109.815 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.1 pp -78.77 -23.68 45.15 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.561 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -87.11 -26.06 23.83 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.432 -0.792 . . . . 0.0 109.281 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.507 ' HG3' ' CG ' ' A' ' 11' ' ' MET . 0.0 OUTLIER -79.99 -54.27 5.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -50.09 -49.46 51.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.162 -0.961 . . . . 0.0 109.454 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -46.58 -49.06 19.43 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.328 -0.858 . . . . 0.0 109.418 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 123.76 21.41 2.41 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.458 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 20.6 m -81.09 -39.26 25.96 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -1.177 . . . . 0.0 109.417 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.507 ' CG ' ' HG3' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -62.02 -16.19 49.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.0 109.856 -179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.89 -28.32 15.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.151 -0.968 . . . . 0.0 109.765 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.527 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 16.9 m -131.64 -39.37 1.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.266 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.635 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 11.4 m-70 -74.87 -168.63 0.76 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.3 -0.875 . . . . 0.0 109.615 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.472 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.6 OUTLIER 166.86 136.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.254 -0.904 . . . . 0.0 109.544 179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD11 HD13 ' A' ' 79' ' ' ILE . 4.1 mm? -42.66 -69.23 0.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.37 -0.832 . . . . 0.0 109.663 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.26 43.73 2.63 Favored 'General case' 0 C--N 1.305 -1.37 0 O-C-N 121.357 -0.84 . . . . 0.0 109.859 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.447 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . . . -132.33 64.28 1.61 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.166 -0.959 . . . . 0.0 109.277 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 18' ' ' ALA . 1.0 OUTLIER -42.64 100.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.418 -0.801 . . . . 0.0 109.845 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HG2' HG23 ' A' ' 21' ' ' VAL . 8.0 ttpm? -112.75 -53.93 2.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.853 . . . . 0.0 109.186 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 37.0 t -126.96 -68.67 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.455 -0.778 . . . . 0.0 109.15 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -84.46 -177.41 51.23 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.599 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -77.97 116.24 3.93 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.653 2.235 . . . . 0.0 110.196 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -42.52 147.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.329 -0.857 . . . . 0.0 109.808 -179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.573 ' CD2' HG12 ' A' ' 76' ' ' ILE . 8.3 m-30 -61.55 -45.66 93.23 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.322 -0.861 . . . . 0.0 109.674 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.73 -43.38 76.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.198 -0.939 . . . . 0.0 109.764 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.05 -40.31 97.33 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.828 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.617 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 72.8 t -60.91 -53.39 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.17 -0.956 . . . . 0.0 109.497 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.51 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -46.76 -49.42 19.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.226 -0.921 . . . . 0.0 109.109 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.5 tptp -48.6 -54.0 16.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.366 -0.834 . . . . 0.0 109.301 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.5 mttt -47.55 -40.66 19.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.407 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 5.4 m-85 -112.39 -127.55 0.28 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.229 -0.919 . . . . 0.0 109.152 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.35 108.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.011 -1.055 . . . . 0.0 109.541 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.17 -2.85 86.97 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.801 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 10.9 ttt180 -60.05 154.71 18.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.247 -1.149 . . . . 0.0 109.658 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.506 ' N ' ' HG2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -51.63 -46.77 63.78 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.723 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -145.34 69.28 1.23 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.279 -0.888 . . . . 0.0 109.605 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.801 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -83.22 -24.39 32.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 0.0 109.498 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 44.0 t -72.34 -49.6 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.91 . . . . 0.0 109.546 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -71.65 -50.53 29.81 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.93 . . . . 0.0 109.667 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -57.06 -44.56 83.16 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.953 . . . . 0.0 109.663 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.506 HD12 ' O ' ' A' ' 38' ' ' ALA . 59.6 mt -61.58 -43.12 99.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.511 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.96 68.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.305 -0.872 . . . . 0.0 109.166 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -69.78 -49.45 35.92 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -17.46 61.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.273 -1.134 . . . . 0.0 109.013 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 3.8 mt -76.59 -41.86 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -99.07 25.98 6.26 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.379 -0.825 . . . . 0.0 109.281 179.8 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 tptt -142.25 11.77 1.96 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.396 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.61 168.44 6.3 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 51' ' ' SER . . . -146.75 167.27 28.21 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 50' ' ' GLY . 40.4 t 174.74 94.92 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.272 -1.134 . . . . 0.0 109.395 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.76 -13.44 6.47 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.583 HG11 ' O2A' ' A' ' 81' ' ' HEC . 41.5 t -82.95 -19.63 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.279 -1.13 . . . . 0.0 109.569 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.617 ' CZ2' HG22 ' A' ' 28' ' ' VAL . 91.5 m95 -139.35 6.38 2.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.164 -0.96 . . . . 0.0 109.904 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 154.55 -140.97 7.81 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.2 m -109.6 -46.08 3.58 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -1.113 . . . . 0.0 109.402 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 56' ' ' SER . 4.7 m -43.04 114.24 1.52 Allowed Pre-proline 0 N--CA 1.486 1.344 0 O-C-N 121.346 -0.846 . . . . 0.0 109.479 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.462 ' HB3' ' HB2' ' A' ' 51' ' ' SER . 34.9 Cg_endo -77.54 113.04 3.45 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.482 2.121 . . . . 0.0 110.691 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.545 ' HE3' ' NB ' ' A' ' 81' ' ' HEC . 1.0 OUTLIER -62.62 140.84 96.96 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 179.743 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' N ' ' HG2' ' A' ' 59' ' ' MET . 34.2 Cg_endo -77.4 154.79 32.02 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.523 2.149 . . . . 0.0 110.474 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.2 Cg_endo -77.53 143.41 21.64 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.707 2.271 . . . . 0.0 110.562 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.889 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 53.9 mm-40 -105.72 164.99 11.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.65 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -97.33 58.87 1.54 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.368 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 ' O ' ' HG3' ' A' ' 47' ' ' LYS . 33.2 m -119.63 151.75 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.531 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -92.35 178.34 5.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.222 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' O ' ' HB2' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -64.08 -20.9 66.27 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.177 -0.952 . . . . 0.0 109.612 -179.89 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.66 -60.76 2.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.211 -0.93 . . . . 0.0 109.213 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 72' ' ' LEU . 33.9 mm-40 -60.51 -38.92 85.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.303 -0.873 . . . . 0.0 109.443 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.18 -27.99 67.73 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.304 -0.872 . . . . 0.0 109.0 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 66' ' ' ASP . 3.4 ttpm? -67.37 -50.0 61.57 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.386 -0.821 . . . . 0.0 109.436 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 2.2 tm0? -69.58 -20.27 63.65 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.253 -0.905 . . . . 0.0 109.518 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' A' ' 76' ' ' ILE . 15.2 mt -81.85 -25.83 34.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -0.924 . . . . 0.0 109.026 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -84.94 -34.56 22.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.19 -0.944 . . . . 0.0 108.737 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.18 -37.37 53.79 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.575 ' CZ2' ' O ' ' A' ' 1' ' ' ASN . 12.2 t90 -77.29 -39.78 46.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.454 -0.779 . . . . 0.0 109.237 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.573 HG12 ' CD2' ' A' ' 25' ' ' TYR . 52.7 mt -68.36 -34.2 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.985 . . . . 0.0 109.754 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD23 ' HA ' ' A' ' 29' ' ' ALA . 76.3 mt -70.8 -43.36 68.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.121 -0.987 . . . . 0.0 109.757 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.3 t -63.99 -27.89 69.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.226 -0.921 . . . . 0.0 109.573 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.868 HD13 HD11 ' A' ' 16' ' ' LEU . 8.2 mt -62.06 99.72 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.202 -0.936 . . . . 0.0 109.236 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.459 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.889 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.487 ' O ' ' CZ2' ' A' ' 75' ' ' TRP . 70.0 m-80 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.359 0.6 . . . . 0.0 109.54 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.565 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 2.2 tt0 -146.26 165.49 29.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.539 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.565 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 84.04 -25.75 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.685 -0.634 . . . . 0.0 110.071 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.497 ' CD1' ' OE1' ' A' ' 71' ' ' GLN . 5.9 mt -88.91 -19.88 25.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.005 -1.06 . . . . 0.0 109.16 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.85 -30.98 15.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.332 -0.855 . . . . 0.0 109.424 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -76.51 -54.03 7.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -0.872 . . . . 0.0 109.139 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.1 mm100 -56.75 -74.77 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.26 -0.9 . . . . 0.0 109.343 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 1.027 ' HG2' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -46.74 -53.85 10.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.304 -0.873 . . . . 0.0 109.438 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.19 14.34 3.71 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 14.9 m -60.8 -43.52 98.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.047 -1.266 . . . . 0.0 109.4 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.22 -12.25 60.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.283 -0.885 . . . . 0.0 109.933 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.83 -35.16 80.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.223 -0.923 . . . . 0.0 109.495 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.2 m -119.38 31.54 6.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.234 -0.916 . . . . 0.0 109.333 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.516 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 25.3 m-70 -149.64 -173.39 4.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.881 . . . . 0.0 109.696 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.643 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 162.78 123.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.423 -0.798 . . . . 0.0 109.181 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.422 ' HB3' ' CE ' ' A' ' 17' ' ' LYS . 7.4 mp -42.54 -55.72 3.37 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 109.579 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.422 ' CE ' ' HB3' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -134.2 45.64 2.59 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.688 -0.805 . . . . 0.0 109.795 -179.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -164.35 49.96 0.12 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.168 -0.957 . . . . 0.0 109.322 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' N ' ' CD ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -49.49 164.94 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.494 -0.754 . . . . 0.0 109.99 -179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.09 -65.1 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.4 t -102.05 -41.14 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 19' ' ' LYS . . . -111.67 -170.57 18.78 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.482 ' O ' ' ND1' ' A' ' 14' ' ' HIS . 35.3 Cg_endo -78.23 156.51 29.57 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.649 2.233 . . . . 0.0 110.399 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.643 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.44 157.56 37.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.151 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.472 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 11.4 m-85 -74.87 -37.75 62.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.18 -0.95 . . . . 0.0 109.67 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.454 ' HB1' ' O ' ' A' ' 80' ' ' LYS . . . -58.39 -34.92 71.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.164 -0.96 . . . . 0.0 109.137 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -71.08 -38.25 72.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.323 -0.86 . . . . 0.0 109.43 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.27 -51.41 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.196 -0.94 . . . . 0.0 109.313 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -53.62 -52.17 60.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.268 -0.895 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -52.01 -39.01 58.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.554 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -43.14 86.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.914 . . . . 0.0 109.78 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.73 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.3 m-85 -107.71 -139.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.601 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.73 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.37 112.8 0.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.38 -0.825 . . . . 0.0 109.557 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.82 -17.21 35.98 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 0.4 OUTLIER -82.68 145.42 29.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.585 -0.95 . . . . 0.0 109.023 179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.32 -3.86 58.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.979 . . . . 0.0 109.789 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -125.59 23.8 7.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.336 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.71 -18.31 54.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.294 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.75 -56.74 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.258 -0.901 . . . . 0.0 109.126 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 41' ' ' TYR . 2.5 p30 -65.66 -38.68 90.03 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.233 -0.917 . . . . 0.0 109.205 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.494 ' N ' ' OD1' ' A' ' 40' ' ' ASP . 68.4 t80 -61.81 -46.02 91.35 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.221 -0.924 . . . . 0.0 109.356 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 43' ' ' ALA . 18.4 mt -62.35 -67.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.353 -0.842 . . . . 0.0 109.463 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.24 -32.22 0.47 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.478 -0.764 . . . . 0.0 109.888 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.481 ' HA2' ' HE3' ' A' ' 47' ' ' LYS . . . -69.85 -55.23 9.81 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.3 OUTLIER -70.0 -5.58 27.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.351 -1.088 . . . . 0.0 109.352 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 64.3 mt -93.02 -37.65 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.886 . . . . 0.0 109.371 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.481 ' HE3' ' HA2' ' A' ' 44' ' ' GLY . 13.8 ptpt -76.41 -23.51 54.02 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.299 -0.876 . . . . 0.0 109.256 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 61' ' ' PRO . 27.9 mttp -108.03 -77.46 0.6 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.88 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.35 -106.84 1.46 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 90.04 -138.95 14.79 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 12.0 p 179.02 156.2 0.48 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.17 -1.194 . . . . 0.0 109.613 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 127.19 -13.6 6.64 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 66.6 t -100.69 -17.18 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -1.141 . . . . 0.0 109.222 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -134.08 -30.71 1.18 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.366 -0.834 . . . . 0.0 110.012 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -173.02 -146.27 5.37 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.1 14.94 14.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -1.117 . . . . 0.0 109.394 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.41 123.41 78.97 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.51 89.36 1.33 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.394 2.063 . . . . 0.0 110.411 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 15.4 ttt -66.06 136.7 95.56 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.39 154.53 21.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.652 2.235 . . . . 0.0 110.534 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HB3' ' HA ' ' A' ' 48' ' ' LYS . 36.0 Cg_endo -79.14 171.18 16.64 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.736 2.291 . . . . 0.0 110.175 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.678 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 47.2 mm-40 -130.44 174.12 10.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.53 72.77 0.8 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.904 . . . . 0.0 109.471 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 2.1 m -128.36 163.0 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.43 160.25 16.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.283 -0.886 . . . . 0.0 109.328 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.17 -22.57 29.68 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.213 -0.929 . . . . 0.0 109.319 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB3' ' A' ' 70' ' ' LYS . . . -68.79 -53.69 20.22 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 109.112 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 68' ' ' GLU . 0.4 OUTLIER -58.15 -46.66 85.29 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.272 -0.893 . . . . 0.0 109.324 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -64.43 -24.91 67.79 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.261 -0.899 . . . . 0.0 109.155 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 67' ' ' ALA . 1.9 ttmm -68.12 -42.93 79.48 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.379 -0.826 . . . . 0.0 109.52 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.497 ' OE1' ' CD1' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -73.71 -22.43 59.91 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 -179.952 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 69' ' ' ALA . 41.8 mt -81.02 -25.42 37.2 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.202 -0.936 . . . . 0.0 109.381 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -88.28 -33.1 18.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.217 -0.927 . . . . 0.0 108.69 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -77.44 -34.99 54.43 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.49 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -76.05 -44.79 37.48 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.465 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 50.7 mt -62.62 -48.19 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.166 -0.959 . . . . 0.0 108.913 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 32' ' ' TYR . 13.4 mt -60.54 -40.67 92.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.289 -0.882 . . . . 0.0 108.677 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -57.81 -36.84 72.78 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 76' ' ' ILE . 28.8 mt -58.84 158.22 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.422 -0.798 . . . . 0.0 108.965 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.454 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.422 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 1.027 HBB1 ' HG2' ' A' ' 8' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.2 p30 . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 56.86 29.31 15.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -0.905 . . . . 0.0 109.547 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -142.82 -43.31 0.31 Allowed 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.227 -0.921 . . . . 0.0 109.344 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.0 mt -77.46 -3.12 38.83 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.404 ' HB2' ' HZ3' ' A' ' 75' ' ' TRP . . . -111.78 -6.28 14.32 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.202 -0.937 . . . . 0.0 109.431 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.83 -34.77 6.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.421 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -59.27 -18.34 36.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.444 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.88 -38.44 7.39 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.427 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.48 27.24 2.66 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.532 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 49.0 m -62.84 -40.8 98.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -1.123 . . . . 0.0 109.379 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 15' ' ' ASP . 9.9 mmt -70.13 -12.22 61.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.649 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -50.26 -41.64 50.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.121 -0.987 . . . . 0.0 108.811 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.469 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 8.9 m -116.39 -3.62 11.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.507 -0.746 . . . . 0.0 109.271 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.3 m-70 -103.02 -174.72 2.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 109.669 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.768 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.6 OUTLIER 166.99 120.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.381 -0.825 . . . . 0.0 109.173 -179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.93 HD22 HG21 ' A' ' 79' ' ' ILE . 24.0 mt -47.89 -50.09 27.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.33 -0.856 . . . . 0.0 109.662 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.19 45.41 2.8 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.317 -0.864 . . . . 0.0 109.938 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.78 72.43 0.97 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.154 -0.966 . . . . 0.0 109.857 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -64.36 112.91 3.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.264 -0.898 . . . . 0.0 109.446 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -116.59 -77.13 0.57 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.18 -0.95 . . . . 0.0 109.3 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.469 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 59.6 t -104.75 -36.05 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.174 -0.954 . . . . 0.0 108.824 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.63 178.04 19.67 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.0 Cg_endo -77.69 143.01 20.87 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.621 2.214 . . . . 0.0 110.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.638 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -75.71 147.37 39.43 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.667 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.567 ' CD2' HG12 ' A' ' 76' ' ' ILE . 12.4 m-30 -56.52 -40.69 75.48 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.38 -0.825 . . . . 0.0 109.511 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.91 -46.61 89.96 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.683 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.54 -25.81 67.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.593 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.638 HG23 ' O ' ' A' ' 24' ' ' ALA . 97.8 t -72.24 -63.35 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.174 -0.954 . . . . 0.0 109.508 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 32' ' ' TYR . . . -51.96 -29.88 22.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.318 -0.863 . . . . 0.0 109.456 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.81 -42.78 85.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.247 -0.908 . . . . 0.0 109.148 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.548 ' HE2' ' CZ2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -59.59 -14.28 12.74 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.327 -0.858 . . . . 0.0 109.609 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.755 ' O ' ' HB2' ' A' ' 33' ' ' ALA . 24.3 m-85 -130.84 172.83 11.58 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.201 -0.937 . . . . 0.0 108.719 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 160.78 109.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.378 -0.826 . . . . 0.0 109.379 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 96.82 -13.29 65.34 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.905 -1.678 . . . . 0.0 108.905 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.13 145.81 47.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -1.059 . . . . 0.0 109.409 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HD2' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -102.73 -21.05 14.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -0.865 . . . . 0.0 109.666 -179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -96.33 7.05 47.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.558 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.545 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -66.26 -17.04 64.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG11 ' HE3' ' A' ' 70' ' ' LYS . 19.0 t -80.53 -56.66 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -59.09 -36.01 74.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.265 -0.897 . . . . 0.0 109.248 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.428 ' O ' ' C ' ' A' ' 42' ' ' LEU . 76.0 t80 -66.32 -66.04 0.6 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.274 -0.891 . . . . 0.0 109.37 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 38' ' ' ALA . 12.8 mt -43.29 -67.82 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.274 -0.891 . . . . 0.0 109.441 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -46.28 -37.16 6.96 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.386 -0.821 . . . . 0.0 109.391 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -55.34 -48.77 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.077 -1.609 . . . . 0.0 109.077 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HE3' HG21 ' A' ' 53' ' ' VAL . 8.1 mmtt -78.4 -11.63 59.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -1.109 . . . . 0.0 109.134 179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.845 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.0 mt -72.28 -34.68 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.482 -0.762 . . . . 0.0 109.302 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 16.16 25.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.661 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLY . 5.1 mtmm -144.23 31.42 1.24 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.147 -0.97 . . . . 0.0 109.589 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LYS . . . 43.8 -156.19 0.2 Allowed Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.726 -1.35 . . . . 0.0 109.726 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -167.95 178.03 41.92 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.7 p 174.89 90.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -1.151 . . . . 0.0 109.516 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 128.19 -15.87 6.09 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 HG21 ' HE3' ' A' ' 45' ' ' LYS . 76.9 t -83.06 -25.26 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -1.162 . . . . 0.0 109.602 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 86.2 m95 -137.98 28.8 2.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.143 -0.973 . . . . 0.0 109.656 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.0 -165.27 13.57 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.447 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 40.2 m -83.12 -35.6 25.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.353 -1.087 . . . . 0.0 109.638 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.464 ' H ' HG22 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -41.56 101.7 0.25 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.424 -0.798 . . . . 0.0 109.619 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -79.15 122.25 5.18 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.435 2.09 . . . . 0.0 110.268 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.49 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 10.8 ttt -81.81 141.17 47.5 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.252 -0.905 . . . . 0.0 109.28 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.22 169.89 18.36 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.582 2.188 . . . . 0.0 110.631 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.14 152.64 27.79 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.83 2.353 . . . . 0.0 110.456 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -125.58 166.41 16.75 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.135 -0.978 . . . . 0.0 109.623 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -98.22 91.41 5.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.78 HG12 ' OE1' ' A' ' 68' ' ' GLU . 18.3 m -146.03 149.91 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.175 -0.953 . . . . 0.0 109.791 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.02 173.78 9.09 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -71.25 -19.75 62.32 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.662 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.9 -57.67 3.72 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.213 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.78 ' OE1' HG12 ' A' ' 64' ' ' VAL . 8.7 pt-20 -63.04 -33.35 75.24 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.28 -0.887 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.495 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -66.43 -36.67 83.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.02 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' HE3' HG11 ' A' ' 39' ' ' VAL . 9.7 tttp -70.08 -31.15 68.59 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.381 -0.824 . . . . 0.0 109.503 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.515 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -77.72 -22.89 49.68 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.137 -0.977 . . . . 0.0 109.482 -179.807 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 76' ' ' ILE . 47.7 mt -81.53 -29.12 33.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 108.783 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 42' ' ' LEU . . . -81.78 -36.09 28.86 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.321 -0.862 . . . . 0.0 108.854 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.29 -36.79 58.21 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.515 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 6.1 t90 -69.37 -42.89 74.61 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.567 HG12 ' CD2' ' A' ' 25' ' ' TYR . 49.1 mt -67.75 -39.66 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.158 -0.964 . . . . 0.0 109.27 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.488 HD11 HD12 ' A' ' 42' ' ' LEU . 20.7 mt -56.99 -45.37 83.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.294 -0.879 . . . . 0.0 109.42 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -63.04 -25.97 68.63 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.227 -0.92 . . . . 0.0 109.339 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.93 HG21 HD22 ' A' ' 16' ' ' LEU . 29.3 mt -69.79 92.11 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 109.37 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.536 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.874 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.315 0.579 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.32 -40.93 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.482 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 7' ' ' GLN . 17.1 tp60 -70.05 -31.27 68.81 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.167 -0.958 . . . . 0.0 109.63 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.415 HD13 ' OE1' ' A' ' 71' ' ' GLN . 4.8 mt -64.48 -45.93 85.26 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.432 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.56 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -62.96 -38.35 90.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.216 -0.927 . . . . 0.0 109.3 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -91.15 1.73 56.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.55 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 3' ' ' GLN . 1.3 mm100 -80.54 -38.13 30.21 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.266 -0.896 . . . . 0.0 109.796 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.42 ' HB2' HBB1 ' A' ' 81' ' ' HEC . 32.0 mmtm -94.28 -21.84 18.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.29 -0.881 . . . . 0.0 109.821 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 95.82 49.52 2.11 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.527 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 27.6 m -81.83 -33.73 30.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.157 -1.202 . . . . 0.0 109.371 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.0 mtt -59.21 -18.91 40.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.347 -0.846 . . . . 0.0 109.642 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.76 -24.6 1.46 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.314 -0.866 . . . . 0.0 109.499 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.3 m -133.45 -40.04 0.9 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.229 -0.919 . . . . 0.0 109.741 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.606 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 20.2 m-70 -73.84 -174.86 1.93 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.198 -0.939 . . . . 0.0 110.2 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.636 ' CG ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 163.47 119.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.804 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.7 mp -42.28 -66.09 0.39 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 110.094 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.5 mmtt -125.73 40.51 3.72 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -0.854 . . . . 0.0 109.412 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.636 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -143.05 60.54 1.41 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.183 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.404 ' HG3' ' HB2' ' A' ' 24' ' ' ALA . 1.7 mtmt -50.0 140.41 12.37 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.54 -0.725 . . . . 0.0 110.105 -179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -142.16 -69.43 0.36 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 92.0 t -115.53 -36.67 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.428 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -109.44 177.51 20.12 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.025 -1.63 . . . . 0.0 109.025 179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.52 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.2 Cg_endo -78.17 132.08 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.453 2.102 . . . . 0.0 110.604 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.804 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -50.37 154.74 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.28 -0.887 . . . . 0.0 109.33 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.448 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 8.8 m-85 -68.53 -36.28 78.63 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.229 -0.92 . . . . 0.0 109.658 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.11 -41.92 99.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -69.91 -25.29 63.61 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.18 -0.95 . . . . 0.0 109.616 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.8 HG23 ' O ' ' A' ' 24' ' ' ALA . 57.7 t -74.95 -64.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.152 -0.967 . . . . 0.0 109.694 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -48.53 -39.44 23.39 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 0.0 109.345 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.48 -41.68 98.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.554 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -29.49 70.52 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 109.66 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 11.4 m-85 -104.38 -149.87 0.42 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.627 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 84.1 -33.73 0.07 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.601 -0.687 . . . . 0.0 109.96 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.81 23.04 18.64 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -116.88 164.92 13.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.167 -1.196 . . . . 0.0 109.429 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.405 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -96.88 33.68 1.84 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.963 . . . . 0.0 109.699 -179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.5 OUTLIER 169.66 45.18 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.231 -0.918 . . . . 0.0 109.372 179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -78.4 -20.78 50.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.294 -0.879 . . . . 0.0 109.207 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -74.44 -53.53 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.0 -42.23 73.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.201 -0.937 . . . . 0.0 109.013 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -54.7 -50.16 68.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.358 -0.839 . . . . 0.0 109.333 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.568 HD21 ' CE2' ' A' ' 32' ' ' TYR . 11.8 mt -55.61 -57.07 13.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.36 -0.837 . . . . 0.0 109.316 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.32 -42.32 9.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.445 -0.784 . . . . 0.0 109.828 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.39 -47.25 89.41 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -86.67 1.63 51.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.229 -1.16 . . . . 0.0 109.951 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 42' ' ' LEU . 15.8 mt -87.67 -37.11 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.046 -1.034 . . . . 0.0 109.369 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -90.95 2.67 56.07 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.148 -0.97 . . . . 0.0 109.683 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 -71.7 0.71 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.221 -0.925 . . . . 0.0 109.452 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 117.04 -136.79 12.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' SER . . . 112.19 -143.08 17.43 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 50' ' ' GLY . 65.5 p 177.22 144.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -1.121 . . . . 0.0 109.542 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 147.91 -13.49 1.31 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.9 t -104.52 -31.45 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -1.153 . . . . 0.0 109.548 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.52 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 98.9 m95 -117.34 -6.24 11.26 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.293 -0.88 . . . . 0.0 109.698 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.94 -161.89 29.21 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.691 -1.363 . . . . 0.0 109.691 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.2 m -93.25 -14.18 27.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.337 -1.096 . . . . 0.0 109.453 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG23 ' H ' ' A' ' 57' ' ' VAL . 23.0 t -47.61 112.78 2.25 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.43 82.53 2.36 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.342 2.028 . . . . 0.0 110.431 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.438 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 11.5 ttt -54.38 138.1 59.38 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 0.0 109.295 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.1 Cg_endo -78.99 153.26 25.13 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.467 2.111 . . . . 0.0 110.552 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.82 148.18 25.13 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.647 2.232 . . . . 0.0 110.444 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -112.76 166.59 11.23 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.302 -0.874 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -99.8 80.82 2.38 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.304 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HB ' ' CG ' ' A' ' 68' ' ' GLU . 2.1 m -130.6 151.78 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.737 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.23 160.9 20.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.31 -0.869 . . . . 0.0 108.811 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -59.23 -25.25 63.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.106 -0.996 . . . . 0.0 109.682 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.66 -55.16 9.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.222 -0.924 . . . . 0.0 109.776 -179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -61.27 -35.45 77.33 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.169 -0.957 . . . . 0.0 109.192 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 68' ' ' GLU . . . -67.57 -34.47 77.11 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.167 -0.958 . . . . 0.0 108.716 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.9 mtpp -61.92 -40.32 95.07 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.403 -0.81 . . . . 0.0 108.896 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.436 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.9 tm0? -72.53 -20.91 61.26 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.309 -0.87 . . . . 0.0 108.743 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD13 HMB2 ' A' ' 81' ' ' HEC . 29.6 mt -79.22 -33.0 44.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.191 -0.943 . . . . 0.0 109.333 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.421 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -84.91 -27.8 26.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.232 -0.918 . . . . 0.0 109.134 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.439 ' HG3' ' N ' ' A' ' 75' ' ' TRP . 0.0 OUTLIER -81.64 -33.69 31.25 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.306 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.7 ' CE2' HD11 ' A' ' 79' ' ' ILE . 15.7 t90 -78.11 -43.97 27.46 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.448 ' CD1' ' CE1' ' A' ' 25' ' ' TYR . 59.3 mt -61.97 -38.06 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.906 . . . . 0.0 108.639 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 29' ' ' ALA . 80.1 mt -72.79 -28.29 62.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.372 -0.83 . . . . 0.0 108.974 179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER -82.66 6.11 18.95 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.7 HD11 ' CE2' ' A' ' 75' ' ' TRP . 10.7 mt -102.48 100.0 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.552 ' NZ ' HD23 ' A' ' 16' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.514 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.785 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -101.51 16.3 26.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.517 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -98.45 -44.16 6.61 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.259 -0.901 . . . . 0.0 109.886 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.855 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.1 mt -61.63 -13.91 26.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 110.17 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -103.48 -18.72 14.67 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.091 -1.006 . . . . 0.0 110.07 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.33 -48.94 7.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.107 -0.996 . . . . 0.0 109.911 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.18 -35.9 81.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.236 -0.915 . . . . 0.0 110.053 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' CE ' ' OE2' ' A' ' 68' ' ' GLU . 5.4 mttm -69.21 -56.19 8.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.248 -0.907 . . . . 0.0 109.666 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.89 10.33 3.94 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.473 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 33.0 m -64.78 -37.79 88.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.091 -1.241 . . . . 0.0 109.377 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mmt -65.47 -11.2 40.94 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.368 -0.832 . . . . 0.0 109.69 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.71 -41.61 61.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.125 -0.984 . . . . 0.0 109.164 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.536 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 3.8 m -122.81 30.79 6.29 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.468 -0.77 . . . . 0.0 109.229 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 17.2 m-70 -140.5 -170.93 3.1 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.147 -0.971 . . . . 0.0 110.079 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 164.39 129.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 HD22 HG21 ' A' ' 79' ' ' ILE . 22.0 mt -42.49 -66.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.379 -0.826 . . . . 0.0 109.607 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.87 41.87 3.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.399 -0.813 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.668 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -138.44 73.79 1.45 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.44 -0.788 . . . . 0.0 109.183 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -57.12 146.81 26.51 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.402 -0.811 . . . . 0.0 109.993 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 ptmt -160.26 -97.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 13' ' ' CYS . 69.3 t -74.51 -51.53 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 0.0 108.676 179.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -111.2 -167.14 18.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.544 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.3 Cg_endo -78.95 160.68 27.13 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.614 2.209 . . . . 0.0 110.36 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -83.35 136.41 34.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.566 ' CD2' HG12 ' A' ' 76' ' ' ILE . 4.0 m-30 -49.02 -38.67 24.37 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.322 -0.861 . . . . 0.0 109.575 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.86 -43.15 99.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.253 -0.904 . . . . 0.0 109.549 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.5 -34.16 77.57 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.577 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 54' ' ' TRP . 40.1 t -61.23 -52.46 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.256 -0.903 . . . . 0.0 109.213 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' CB ' HD23 ' A' ' 77' ' ' LEU . . . -53.95 -42.4 68.83 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.21 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -54.63 -46.75 73.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.277 -0.889 . . . . 0.0 109.594 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.575 ' HD2' ' CH2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -66.34 -24.09 66.46 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.951 . . . . 0.0 109.905 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 24.4 m-85 -125.64 -145.57 0.33 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.185 -0.947 . . . . 0.0 109.428 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.732 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.92 109.82 0.07 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.441 -0.787 . . . . 0.0 109.498 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.77 14.11 81.72 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 108.879 -1.688 . . . . 0.0 108.879 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 0.0 OUTLIER -82.97 36.92 0.52 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.393 -1.063 . . . . 0.0 110.553 -179.799 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 37' ' ' ASP . 4.0 mtpp 69.73 -4.7 1.36 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.313 -0.867 . . . . 0.0 111.217 179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.487 ' CB ' ' O ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER 167.05 52.87 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.736 -1.227 . . . . 0.0 109.686 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -63.75 -20.98 66.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.11 -0.994 . . . . 0.0 109.116 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.5 HG12 ' HG2' ' A' ' 70' ' ' LYS . 9.8 t -78.46 -66.01 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.389 -0.82 . . . . 0.0 109.543 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -49.19 -51.07 34.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.349 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.4 t80 -57.76 -59.83 4.62 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.255 -0.903 . . . . 0.0 109.59 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 38' ' ' ALA . 18.5 mt -47.13 -75.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.807 -179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' HB1' ' A' ' 69' ' ' ALA . . . -44.03 -26.28 0.28 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.521 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -65.16 -50.24 57.95 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' CGA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -83.81 -2.63 56.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.266 -1.138 . . . . 0.0 109.637 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 43' ' ' ALA . 28.3 mt -83.41 -42.31 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.194 -0.941 . . . . 0.0 109.571 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.43 1.66 44.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.901 . . . . 0.0 109.757 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.03 3.84 12.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.258 -0.901 . . . . 0.0 109.51 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 85.81 -174.1 47.73 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' O ' ' CB ' ' A' ' 51' ' ' SER . . . -138.31 154.35 22.89 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.477 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.1 OUTLIER 168.27 81.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.129 -1.218 . . . . 0.0 110.061 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 138.01 -34.19 2.17 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.4 t -71.33 -14.87 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.267 -1.137 . . . . 0.0 109.647 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.575 ' CH2' ' HD2' ' A' ' 31' ' ' LYS . 77.2 m95 -139.98 16.15 2.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 130.32 -156.38 21.53 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.419 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 15.2 m -100.9 34.25 2.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.25 -1.147 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 51' ' ' SER . 2.3 t -85.94 114.74 58.66 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.302 -0.874 . . . . 0.0 109.2 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HA ' ' HB3' ' A' ' 51' ' ' SER . 35.3 Cg_endo -77.74 72.34 6.13 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.307 2.005 . . . . 0.0 110.671 -179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.528 ' SD ' ' ND ' ' A' ' 81' ' ' HEC . 7.1 ttt -61.57 137.32 94.83 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 109.073 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 35.7 Cg_endo -77.93 145.85 22.75 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 122.478 2.119 . . . . 0.0 110.554 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 34.9 Cg_endo -77.95 157.93 30.89 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.553 2.169 . . . . 0.0 110.533 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.839 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 28.2 mm-40 -118.46 158.9 24.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 109.278 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -88.67 47.16 1.46 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.101 -1.0 . . . . 0.0 109.514 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -92.2 157.23 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.173 -0.955 . . . . 0.0 109.72 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -88.8 -171.65 3.39 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.352 -0.843 . . . . 0.0 109.079 179.59 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.415 ' H ' HG22 ' A' ' 65' ' ' THR . 68.2 t0 -79.86 -31.18 40.41 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.054 -1.029 . . . . 0.0 109.603 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.71 -39.66 84.33 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.109 -0.995 . . . . 0.0 109.253 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 11.6 mt-10 -66.83 -51.69 52.57 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.402 -0.811 . . . . 0.0 109.433 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.451 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -60.6 -30.0 69.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 39' ' ' VAL . 0.0 OUTLIER -69.34 -36.8 77.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.213 -0.929 . . . . 0.0 109.578 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.855 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -75.84 -22.9 55.79 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.278 -0.889 . . . . 0.0 109.824 -179.826 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.498 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 41.1 mt -80.43 -28.14 37.84 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.142 -0.974 . . . . 0.0 109.316 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.411 ' HB1' ' CD1' ' A' ' 42' ' ' LEU . . . -84.26 -38.4 20.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.485 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -71.84 -36.15 70.1 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.89 . . . . 0.0 108.677 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.741 ' CZ2' HD11 ' A' ' 79' ' ' ILE . 7.0 t90 -74.25 -47.17 36.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.444 -0.785 . . . . 0.0 108.935 179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.566 HG12 ' CD2' ' A' ' 25' ' ' TYR . 50.2 mt -55.8 -32.76 32.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.314 -0.866 . . . . 0.0 109.443 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.632 HD22 ' HB2' ' A' ' 33' ' ' ALA . 69.7 mt -78.44 -37.82 42.79 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.183 -0.948 . . . . 0.0 109.498 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.4 t -83.84 4.47 29.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 109.79 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.741 HD11 ' CZ2' ' A' ' 75' ' ' TRP . 2.8 mt -72.17 155.32 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.125 -0.984 . . . . 0.0 109.123 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.402 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.839 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -179.57 -34.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.27 -0.894 . . . . 0.0 109.343 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -59.17 -40.88 87.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.343 -0.848 . . . . 0.0 109.39 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.19 -19.28 62.42 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.357 -0.839 . . . . 0.0 109.472 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.557 ' HB2' ' CZ3' ' A' ' 75' ' ' TRP . . . -96.71 0.64 49.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.263 -0.898 . . . . 0.0 109.567 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mmtm -110.54 -66.74 1.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.166 -0.959 . . . . 0.0 109.613 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.411 ' O ' ' C ' ' A' ' 8' ' ' LYS . 92.9 mm-40 -52.14 -57.87 8.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -0.937 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.703 ' HD3' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -43.58 -42.89 5.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 0.0 109.428 -179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 100.28 39.24 3.31 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.603 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.8 m -88.0 -50.88 6.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -1.162 . . . . 0.0 109.575 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.454 ' HA ' ' HB2' ' A' ' 14' ' ' HIS . 14.7 mtt -58.28 -15.48 10.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.231 -0.918 . . . . 0.0 109.862 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -48.17 -33.72 8.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.154 -0.966 . . . . 0.0 109.127 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 38.4 m -119.46 -13.18 9.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.418 -0.801 . . . . 0.0 109.1 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.526 ' NE2' ' NA ' ' A' ' 81' ' ' HEC . 33.4 m-70 -95.59 -176.86 3.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.354 -0.841 . . . . 0.0 109.692 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.587 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.3 OUTLIER 173.19 136.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.385 -0.822 . . . . 0.0 109.235 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.819 HD22 HG21 ' A' ' 79' ' ' ILE . 16.7 mt -62.92 -48.88 77.04 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.835 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -127.49 43.22 3.17 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.34 -0.85 . . . . 0.0 109.851 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.58 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -152.73 81.32 1.22 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.347 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.16 90.5 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.35 -0.844 . . . . 0.0 109.657 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.453 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.9 mptt -89.97 -156.52 0.42 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.905 . . . . 0.0 109.335 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.431 ' C ' ' O ' ' A' ' 20' ' ' LYS . 84.3 t -43.16 -30.6 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.154 -0.966 . . . . 0.0 109.024 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -109.87 176.32 19.2 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.29 -1.524 . . . . 0.0 109.29 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.444 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.1 Cg_endo -77.86 129.96 10.2 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.562 2.175 . . . . 0.0 110.6 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -56.68 140.24 47.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.165 -0.959 . . . . 0.0 109.084 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.81 ' HB3' HG23 ' A' ' 76' ' ' ILE . 18.1 m-85 -56.25 -41.42 75.72 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.309 -0.869 . . . . 0.0 109.823 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.98 -42.42 98.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.188 -0.945 . . . . 0.0 109.787 -179.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -68.32 -25.47 65.13 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 109.725 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 24' ' ' ALA . 72.7 t -69.14 -58.77 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 O-C-N 121.233 -0.917 . . . . 0.0 109.705 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.02 -43.99 82.4 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -62.37 -34.01 75.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.28 -0.887 . . . . 0.0 109.249 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.581 ' HD3' ' CZ2' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -60.08 -27.11 66.71 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.316 -0.865 . . . . 0.0 109.467 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.653 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 33.1 m-85 -98.27 -101.89 0.2 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.175 -0.953 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.653 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 72.37 104.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.901 -1.125 . . . . 0.0 109.296 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.33 -7.39 80.44 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -83.82 116.46 22.74 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.342 -1.093 . . . . 0.0 109.355 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.24 4.81 16.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.683 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -126.9 24.99 6.38 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 109.626 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.633 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -77.86 -27.27 49.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.22 -0.925 . . . . 0.0 109.139 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 73' ' ' ALA . 39.6 t -80.37 -51.95 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.332 -0.855 . . . . 0.0 109.16 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.17 -45.62 87.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.223 179.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.469 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 21.0 t80 -56.81 -58.31 8.65 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.89 . . . . 0.0 109.375 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 38' ' ' ALA . 49.4 mt -47.41 -62.29 1.5 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.266 -0.896 . . . . 0.0 109.347 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.28 -40.49 3.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.435 -0.79 . . . . 0.0 109.55 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.24 -51.9 55.75 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' CBA' ' A' ' 81' ' ' HEC . 0.0 OUTLIER -76.49 -3.14 35.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.205 -1.174 . . . . 0.0 109.603 179.977 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' A' ' 43' ' ' ALA . 25.1 mt -85.58 -41.27 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.158 -0.964 . . . . 0.0 109.453 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.29 -8.3 39.44 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.224 -0.922 . . . . 0.0 109.564 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 -12.74 9.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.304 -0.872 . . . . 0.0 109.751 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 48.93 -138.65 14.58 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 117.44 -153.38 17.29 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -173.65 143.32 1.0 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.16 -1.2 . . . . 0.0 109.636 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 129.06 -15.14 5.89 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.0 t -93.43 -22.9 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -1.094 . . . . 0.0 109.491 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.581 ' CZ2' ' HD3' ' A' ' 31' ' ' LYS . 82.5 m95 -131.98 20.79 4.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.97 -132.65 6.79 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.446 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -127.75 -1.44 6.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.172 -1.193 . . . . 0.0 109.625 -179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.2 t -65.82 113.32 11.54 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.105 -0.997 . . . . 0.0 109.43 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.4 Cg_endo -78.45 111.28 3.0 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.392 2.061 . . . . 0.0 110.7 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.477 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -90.51 134.96 29.96 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.189 -0.944 . . . . 0.0 108.989 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.477 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.41 155.57 28.51 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.46 2.107 . . . . 0.0 110.355 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.52 141.45 17.69 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.659 2.239 . . . . 0.0 110.438 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.864 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 7.2 mm-40 -111.63 176.09 5.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 0.0 109.324 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -102.15 60.98 0.85 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.211 -0.931 . . . . 0.0 109.391 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.428 HG22 ' H ' ' A' ' 64' ' ' VAL . 10.6 m -90.96 151.14 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.415 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 68' ' ' GLU . 0.1 OUTLIER -80.92 153.43 27.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.227 -0.921 . . . . 0.0 109.078 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -49.11 -69.57 0.11 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.154 -0.966 . . . . 0.0 109.686 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -45.87 -27.77 0.95 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.125 -0.985 . . . . 0.0 109.528 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -66.14 -54.53 24.37 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.219 -0.926 . . . . 0.0 109.929 -179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.9 -34.83 65.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.4 mttm -63.74 -50.53 68.71 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.34 -0.85 . . . . 0.0 109.538 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.529 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.9 OUTLIER -64.72 -21.41 66.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.848 -179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.613 HD13 ' CMB' ' A' ' 81' ' ' HEC . 46.9 mt -75.77 -36.8 59.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 0.0 109.742 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.544 ' HB3' HG13 ' A' ' 39' ' ' VAL . . . -77.41 -44.28 29.71 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.149 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.636 ' HA ' HD12 ' A' ' 77' ' ' LEU . 3.7 mt-30 -68.05 -32.17 72.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.144 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.557 ' CZ3' ' HB2' ' A' ' 5' ' ' ALA . 6.3 t90 -72.05 -46.78 55.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 109.169 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.81 HG23 ' HB3' ' A' ' 25' ' ' TYR . 45.5 mt -60.74 -36.34 70.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.636 HD12 ' HA ' ' A' ' 74' ' ' GLN . 15.1 mt -65.24 -46.61 79.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -18.95 60.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.338 -0.851 . . . . 0.0 109.43 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.819 HG21 HD22 ' A' ' 16' ' ' LEU . 45.3 mt -72.17 100.89 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.349 -0.844 . . . . 0.0 109.579 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.394 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.864 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.418 ' O ' ' CB ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -131.15 138.34 49.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.485 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.418 ' CB ' ' O ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER 169.95 -44.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.33 -0.856 . . . . 0.0 109.196 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.65 HD13 ' OE1' ' A' ' 71' ' ' GLN . 0.4 OUTLIER -68.68 -27.94 66.42 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 108.935 179.498 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.66 -35.0 76.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.368 -0.832 . . . . 0.0 109.41 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.99 -28.76 68.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.166 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -73.63 -68.55 0.5 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.255 -0.903 . . . . 0.0 109.741 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.404 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -50.22 -51.46 44.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.389 -0.819 . . . . 0.0 109.401 179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.81 54.94 0.58 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 19.9 m -91.21 -33.41 15.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.251 -1.146 . . . . 0.0 109.391 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.424 ' CE ' HD21 ' A' ' 16' ' ' LEU . 5.6 mmt -65.61 -17.3 64.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.84 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -53.66 -33.77 56.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.143 -0.973 . . . . 0.0 109.104 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.95 31.03 5.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.333 -0.855 . . . . 0.0 109.177 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.49 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 39.8 m-70 -139.3 -177.77 5.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.166 -0.959 . . . . 0.0 110.013 -179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.788 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -176.8 145.77 0.53 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.899 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.908 HD12 HG21 ' A' ' 79' ' ' ILE . 2.6 mm? -85.49 -9.89 56.81 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.134 -0.979 . . . . 0.0 109.741 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -124.35 42.71 3.19 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.165 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 24' ' ' ALA . . . 55.39 -179.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 110.116 179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' ALA . 4.6 mtmt 70.53 101.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-O 121.391 0.615 . . . . 0.0 109.728 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.48 ' HG3' ' OD1' ' A' ' 15' ' ' ASP . 0.7 OUTLIER 167.22 -166.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.437 -0.789 . . . . 0.0 109.112 179.913 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 55.1 t -81.85 -69.85 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.099 -1.001 . . . . 0.0 109.194 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -74.23 -172.52 27.5 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -77.59 109.6 2.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.488 2.125 . . . . 0.0 110.498 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.788 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -44.41 143.52 1.26 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.34 -0.85 . . . . 0.0 109.401 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.663 ' HB2' HD13 ' A' ' 16' ' ' LEU . 13.2 m-30 -55.04 -44.12 74.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.26 -0.9 . . . . 0.0 109.244 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.664 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -54.86 -50.06 69.6 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.247 -0.908 . . . . 0.0 109.458 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.78 -24.3 66.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.443 -0.786 . . . . 0.0 110.124 -179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' ALA . 40.5 t -68.7 -62.51 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.056 -1.028 . . . . 0.0 108.929 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -55.13 -25.68 33.43 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.41 -0.806 . . . . 0.0 108.83 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.92 -47.06 75.98 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.331 -0.856 . . . . 0.0 109.452 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.14 -23.99 66.9 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.752 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.677 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 26.4 m-85 -104.37 -111.63 0.25 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.07 105.63 0.07 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.818 -1.176 . . . . 0.0 109.293 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.39 -9.33 74.46 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.986 ' HB2' ' HB2' ' A' ' 38' ' ' ALA . 3.4 mmm180 -58.32 117.0 3.97 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.15 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -40.49 95.33 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -0.89 . . . . 0.0 109.694 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -111.13 46.11 1.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.986 ' HB2' ' HB2' ' A' ' 35' ' ' ARG . . . -80.6 -19.56 45.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -78.11 -51.35 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.527 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -67.66 -39.1 84.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.343 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -64.11 -55.13 24.13 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.658 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.616 HD21 ' HE2' ' A' ' 32' ' ' TYR . 24.6 mt -58.84 -63.72 1.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -0.941 . . . . 0.0 109.714 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.439 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.51 -37.24 2.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.373 -0.829 . . . . 0.0 109.441 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.92 -49.36 79.01 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.82 -4.5 56.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -1.139 . . . . 0.0 109.682 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.439 HD12 ' HA ' ' A' ' 43' ' ' ALA . 20.0 mt -82.18 -36.03 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.173 -0.955 . . . . 0.0 109.312 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 64' ' ' VAL . 3.5 tttm -90.79 -11.65 38.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.125 -0.984 . . . . 0.0 109.338 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 14.4 mtpp -111.8 -76.88 0.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.245 -0.909 . . . . 0.0 109.584 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 115.84 -114.76 3.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 82.9 -172.27 51.54 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.599 -1.401 . . . . 0.0 109.599 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.409 ' OG ' ' HA ' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -145.37 151.52 38.41 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.118 -1.225 . . . . 0.0 109.653 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 133.95 -13.54 4.71 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.1 t -95.55 -23.71 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -1.149 . . . . 0.0 109.567 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 67.8 m95 -123.79 24.81 8.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.9 -118.21 4.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.0 OUTLIER -128.98 30.7 5.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.755 -179.802 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' O ' ' HB3' ' A' ' 51' ' ' SER . 2.9 t -93.72 111.0 50.81 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.232 -0.918 . . . . 0.0 109.101 179.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 56' ' ' SER . 36.3 Cg_endo -78.35 115.49 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.405 2.07 . . . . 0.0 110.72 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.412 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 11.9 ttt -97.78 136.21 21.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.268 -0.895 . . . . 0.0 108.96 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.79 154.34 23.23 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.562 2.174 . . . . 0.0 110.697 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.34 137.13 16.52 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.59 2.194 . . . . 0.0 110.129 179.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.949 ' HG2' HBB2 ' A' ' 81' ' ' HEC . 1.7 mp0 -95.67 -171.84 2.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.667 -179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -115.86 76.0 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.529 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' O ' ' HD2' ' A' ' 47' ' ' LYS . 0.1 OUTLIER -131.56 154.42 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 109.435 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 13.2 t -83.27 -171.93 3.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.271 -0.893 . . . . 0.0 109.245 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.8 -40.1 49.2 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.334 -0.854 . . . . 0.0 109.601 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.85 -55.05 40.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.548 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -55.73 -43.3 76.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.209 -0.932 . . . . 0.0 109.62 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.02 -37.79 74.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 109.649 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -64.31 -48.96 73.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.352 -0.843 . . . . 0.0 109.771 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.65 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.9 OUTLIER -64.09 -24.2 67.61 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.181 -0.949 . . . . 0.0 110.064 -179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 82.7 mt -76.84 -31.11 56.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.067 -1.02 . . . . 0.0 109.763 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.53 -48.47 15.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.015 -1.053 . . . . 0.0 108.995 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -66.96 -32.73 74.17 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.292 -0.88 . . . . 0.0 108.807 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.651 ' CE2' HD11 ' A' ' 79' ' ' ILE . 9.1 t90 -69.51 -48.33 60.89 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.415 -0.803 . . . . 0.0 109.451 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 26.6 mt -55.4 -49.12 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.096 -1.002 . . . . 0.0 109.429 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 29.5 mt -55.44 -46.03 76.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.157 -0.964 . . . . 0.0 109.768 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.5 m -61.41 -34.15 74.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.155 -0.965 . . . . 0.0 109.68 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.908 HG21 HD12 ' A' ' 16' ' ' LEU . 12.3 mt -56.44 111.45 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.286 -0.884 . . . . 0.0 109.436 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.372 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.982 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -118.77 75.67 1.04 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.328 -0.858 . . . . 0.0 109.432 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.47 -55.22 0.08 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.205 -0.935 . . . . 0.0 109.665 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.491 HD21 ' NE2' ' A' ' 71' ' ' GLN . 1.8 pp -65.18 -28.44 69.39 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.098 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.456 ' N ' ' HG ' ' A' ' 4' ' ' LEU . . . -68.15 -34.49 76.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.38 -0.825 . . . . 0.0 108.992 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -27.14 63.58 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.409 -0.807 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' O ' ' C ' ' A' ' 8' ' ' LYS . 32.8 mt-30 -79.45 -69.31 0.59 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.248 -0.907 . . . . 0.0 109.598 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.453 ' HB3' HBB1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -43.18 -51.15 6.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.44 -0.787 . . . . 0.0 109.526 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.65 41.82 0.99 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.554 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 47.9 m -84.76 -33.01 23.12 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.152 -1.205 . . . . 0.0 109.436 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 mtt -77.49 -10.77 59.67 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.333 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -49.4 -33.32 13.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.88 . . . . 0.0 109.298 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 m -130.42 14.97 5.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.52 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 24.0 m-70 -127.11 -175.91 3.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.329 -0.857 . . . . 0.0 109.587 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.949 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.3 OUTLIER 162.74 135.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.35 -0.844 . . . . 0.0 109.377 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.692 HD11 HD13 ' A' ' 79' ' ' ILE . 10.9 mp -49.66 -59.72 3.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 109.774 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -125.31 43.02 3.15 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.255 -0.903 . . . . 0.0 109.906 -179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.949 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -135.32 54.67 1.92 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 7.1 pttt -54.12 115.99 2.35 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.414 -0.804 . . . . 0.0 110.132 -179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.472 ' HG2' HG23 ' A' ' 21' ' ' VAL . 7.6 ttmt -131.56 -95.8 0.35 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.772 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 20' ' ' LYS . 48.4 t -77.38 -48.39 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.038 -1.039 . . . . 0.0 108.696 179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -103.42 174.28 22.76 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.607 ' HG3' ' CG ' ' A' ' 54' ' ' TRP . 34.4 Cg_endo -77.82 132.51 11.93 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.542 2.161 . . . . 0.0 110.413 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.575 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -49.93 155.84 0.84 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.486 ' CE1' ' CD1' ' A' ' 76' ' ' ILE . 7.9 m-85 -69.47 -33.83 73.48 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.33 -0.856 . . . . 0.0 109.603 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.92 -39.77 93.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.676 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 31' ' ' LYS . 1.3 m-20 -69.26 -29.64 67.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 0.0 109.774 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.8 t -70.81 -61.1 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.84 31.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.321 -0.862 . . . . 0.0 109.733 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.5 -36.56 81.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.218 -0.926 . . . . 0.0 109.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -74.13 -9.62 58.8 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.247 -0.908 . . . . 0.0 109.645 -179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.43 4.81 6.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.154 -0.966 . . . . 0.0 109.847 -179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.42 -27.76 69.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.525 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.92 19.61 37.07 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.622 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 15.7 tpt180 -105.29 144.29 32.28 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.302 -1.116 . . . . 0.0 109.447 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.19 -35.41 31.42 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.517 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.75 58.71 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.923 . . . . 0.0 109.734 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.693 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.25 -15.64 61.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.237 -0.914 . . . . 0.0 109.441 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.439 HG22 HD12 ' A' ' 77' ' ' LEU . 42.2 t -74.95 -57.5 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -0.895 . . . . 0.0 109.766 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -63.59 -43.66 96.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.122 -0.986 . . . . 0.0 109.28 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 45' ' ' LYS . 26.2 t80 -57.21 -54.53 45.76 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.412 -0.805 . . . . 0.0 109.736 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.693 HD12 ' O ' ' A' ' 38' ' ' ALA . 7.6 mt -57.83 -64.66 0.83 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.274 -0.891 . . . . 0.0 110.051 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.67 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -39.91 -41.47 1.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.554 -0.716 . . . . 0.0 110.011 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.68 -53.4 46.42 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.573 ' HE2' ' CE2' ' A' ' 41' ' ' TYR . 7.6 mtmp? -74.1 -5.51 42.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -1.134 . . . . 0.0 109.722 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.67 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.2 mt -83.46 -36.8 12.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.941 . . . . 0.0 109.388 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -76.41 -46.2 28.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.156 -0.965 . . . . 0.0 109.475 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.68 -52.6 11.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 45' ' ' LYS . . . 141.51 -157.45 26.19 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . -144.79 163.19 28.01 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' A' ' 58' ' ' PRO . 1.6 t 177.87 84.26 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.194 -1.18 . . . . 0.0 109.717 -179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 121.02 -17.19 9.24 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG12 ' CD1' ' A' ' 54' ' ' TRP . 60.4 t -80.41 -22.24 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.358 -1.084 . . . . 0.0 109.484 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.607 ' CG ' ' HG3' ' A' ' 23' ' ' PRO . 95.1 m95 -144.83 35.63 1.14 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 0.0 109.526 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.67 -165.41 12.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.6 OUTLIER -87.39 -38.31 16.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.293 -1.122 . . . . 0.0 109.649 -179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 57' ' ' VAL . 3.2 p -43.3 103.61 0.33 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.199 -0.938 . . . . 0.0 109.57 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 35.7 Cg_endo -78.49 114.43 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.392 2.061 . . . . 0.0 110.28 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.485 ' CG ' ' HD2' ' A' ' 60' ' ' PRO . 5.4 ttt -67.61 141.0 94.88 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.237 -0.914 . . . . 0.0 109.314 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -78.86 164.85 24.99 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.585 2.19 . . . . 0.0 110.631 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.4 138.35 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.733 2.289 . . . . 0.0 110.219 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -108.16 165.11 11.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.452 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 4.8 p-10 -97.64 83.36 3.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.413 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 3.5 m -141.3 151.01 19.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.892 . . . . 0.0 109.528 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -174.19 4.21 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.89 -21.84 65.99 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.305 -0.872 . . . . 0.0 109.379 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.35 -54.41 10.86 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.327 -0.858 . . . . 0.0 109.483 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.769 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.4 OUTLIER -60.33 -35.55 75.89 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 109.783 -179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.34 -25.91 61.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.239 -0.913 . . . . 0.0 109.587 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 0.1 OUTLIER -77.21 -42.58 36.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.216 -0.928 . . . . 0.0 109.7 -179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.491 ' NE2' HD21 ' A' ' 4' ' ' LEU . 4.6 tm0? -73.3 -21.64 60.53 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.449 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.769 HD12 ' O ' ' A' ' 68' ' ' GLU . 11.6 mt -82.73 -33.69 27.43 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.512 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.46 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -85.28 -22.85 28.41 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.142 -0.974 . . . . 0.0 108.611 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 70' ' ' LYS . 1.6 mt-30 -82.73 -40.08 21.04 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.85 ' CE2' HD11 ' A' ' 79' ' ' ILE . 7.1 t90 -76.35 -42.02 46.26 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.499 ' CG1' ' O ' ' A' ' 72' ' ' LEU . 65.3 mt -61.53 -48.76 87.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -0.897 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 77' ' ' LEU . 17.2 mt -57.22 -37.91 72.95 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.223 -0.923 . . . . 0.0 108.645 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -64.93 -32.32 73.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.85 HD11 ' CE2' ' A' ' 75' ' ' TRP . 29.5 mt -69.07 123.07 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.0 109.352 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.533 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.84 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.1 m120 . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 49.26 85.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.282 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -170.66 -62.31 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -63.11 -28.67 70.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.451 -0.781 . . . . 0.0 109.732 -179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.518 ' HB1' ' HB2' ' A' ' 10' ' ' CYS . . . -90.69 -11.62 39.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.891 . . . . 0.0 109.672 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -63.7 1.27 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.224 -0.923 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -40.34 26.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.202 -0.936 . . . . 0.0 109.528 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' HE3' HG12 ' A' ' 64' ' ' VAL . 36.1 mmtt -62.21 -53.09 60.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.484 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 125.93 10.03 4.49 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.539 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 25.4 m -64.05 -31.34 72.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.053 -1.263 . . . . 0.0 109.412 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -14.09 60.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.408 -0.807 . . . . 0.0 109.778 -179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -51.63 -34.44 37.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.916 . . . . 0.0 109.381 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.403 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 11.2 m -121.23 -38.04 2.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.301 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.537 ' CG ' ' CE1' ' A' ' 25' ' ' TYR . 45.9 m-70 -62.09 -174.86 0.06 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.0 109.575 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.5 OUTLIER 170.7 127.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.27 -0.894 . . . . 0.0 109.703 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.594 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 1.2 mm? -42.36 -71.73 0.08 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.436 -0.79 . . . . 0.0 109.456 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -125.63 40.4 3.75 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.44 -0.787 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB3' ' CG ' ' A' ' 15' ' ' ASP . . . -147.95 63.97 1.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.363 -0.836 . . . . 0.0 109.149 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.46 ' HB3' ' N ' ' A' ' 24' ' ' ALA . 0.3 OUTLIER -63.81 104.73 0.72 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.427 -0.796 . . . . 0.0 109.814 -179.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -91.71 -74.46 0.51 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.164 -0.96 . . . . 0.0 109.242 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 2.4 t -94.35 -35.99 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.419 -0.801 . . . . 0.0 109.215 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' HA2' HMD3 ' A' ' 81' ' ' HEC . . . -111.36 -178.49 20.28 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.02 146.0 22.63 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.538 2.158 . . . . 0.0 110.515 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 16' ' ' LEU . . . -74.15 140.65 45.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -0.905 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.537 ' CE1' ' CG ' ' A' ' 14' ' ' HIS . 20.5 m-85 -50.6 -45.13 57.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.21 -0.931 . . . . 0.0 109.988 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.487 ' HB1' ' OXT' ' A' ' 80' ' ' LYS . . . -48.06 -42.99 30.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 110.147 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.08 -32.08 68.63 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.089 -1.007 . . . . 0.0 110.096 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.26 -58.49 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.084 -1.01 . . . . 0.0 109.334 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.643 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -52.92 -54.4 35.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.031 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.12 -30.21 47.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.379 -0.826 . . . . 0.0 109.048 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.3 tptp -59.29 -43.67 92.54 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.415 -0.803 . . . . 0.0 109.421 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.711 ' CE2' HD21 ' A' ' 42' ' ' LEU . 87.8 m-85 -88.94 -103.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 108.945 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 75.4 106.98 0.08 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.876 -1.14 . . . . 0.0 109.737 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.21 -12.07 70.28 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.111 -1.595 . . . . 0.0 109.111 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.618 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 1.2 ttt180 -79.72 100.48 7.92 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.384 -1.068 . . . . 0.0 109.218 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.9 -9.32 28.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.33 -0.856 . . . . 0.0 109.698 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -112.7 27.27 9.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.95 . . . . 0.0 109.583 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.713 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -84.66 -30.24 25.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.163 -0.96 . . . . 0.0 109.758 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.661 ' HA ' ' HB1' ' A' ' 73' ' ' ALA . 40.9 t -69.49 -43.1 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.232 -0.918 . . . . 0.0 109.242 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.83 -55.58 6.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.496 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -50.57 -52.44 39.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.414 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.713 HD12 ' O ' ' A' ' 38' ' ' ALA . 41.0 mt -50.6 -64.67 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.429 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -42.67 -31.71 0.49 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.503 -0.748 . . . . 0.0 109.573 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.79 -56.98 10.57 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -71.49 -4.35 26.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.272 -1.134 . . . . 0.0 109.469 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.625 HD12 ' HA ' ' A' ' 43' ' ' ALA . 38.5 mt -83.58 -45.38 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.175 -0.953 . . . . 0.0 109.364 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.0 tttt -83.85 5.39 25.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.195 -0.94 . . . . 0.0 109.651 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.3 mmtt -126.71 -78.84 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.084 -1.01 . . . . 0.0 109.402 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 130.16 -143.72 14.98 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 115.19 -160.96 12.96 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 57' ' ' VAL . 71.6 p -175.01 157.76 2.38 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.313 -1.11 . . . . 0.0 109.352 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 135.24 -22.9 3.52 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.0 t -86.4 -26.48 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -1.138 . . . . 0.0 109.321 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -127.25 -30.34 2.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.32 -0.863 . . . . 0.0 109.776 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.96 -169.4 37.49 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 57' ' ' VAL . 1.9 t -90.82 -19.69 23.15 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.316 -1.108 . . . . 0.0 109.447 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.692 HG13 ' O ' ' A' ' 57' ' ' VAL . 7.4 p -44.86 116.45 2.79 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 109.267 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.93 112.9 3.35 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.373 2.049 . . . . 0.0 110.775 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 4.5 ttt -84.58 136.62 39.44 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.212 -0.93 . . . . 0.0 108.762 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.46 160.27 22.52 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.614 2.209 . . . . 0.0 110.906 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.96 140.36 18.07 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 109.513 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 1.01 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 45.1 mm-40 -107.35 160.43 15.63 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.057 -1.027 . . . . 0.0 109.937 -179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.51 102.38 14.86 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.385 -0.822 . . . . 0.0 109.312 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 HG12 ' HE3' ' A' ' 8' ' ' LYS . 19.6 m -152.47 165.19 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.176 -0.953 . . . . 0.0 109.581 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.7 p -96.85 -171.63 2.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.279 -0.888 . . . . 0.0 109.086 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -81.21 -36.44 30.04 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.107 -0.996 . . . . 0.0 109.62 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -67.3 -39.2 85.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.159 -0.963 . . . . 0.0 109.102 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -65.0 -51.53 61.16 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.318 -0.864 . . . . 0.0 109.294 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.664 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -57.34 -36.6 71.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.347 -0.846 . . . . 0.0 109.241 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -57.94 -47.81 81.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.536 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 1.1 tm0? -65.77 -22.58 66.59 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.358 -0.839 . . . . 0.0 109.484 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 69' ' ' ALA . 6.3 mt -79.66 -26.48 41.03 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.074 -1.016 . . . . 0.0 109.385 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.661 ' HB1' ' HA ' ' A' ' 39' ' ' VAL . . . -81.66 -41.84 20.81 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.244 -0.91 . . . . 0.0 108.986 179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -73.32 -35.11 66.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.327 -0.858 . . . . 0.0 108.733 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.536 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 12.8 t90 -73.03 -40.41 65.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 109.432 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 72' ' ' LEU . 17.6 mt -69.13 -34.07 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.111 -0.993 . . . . 0.0 109.818 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.643 HD23 ' HA ' ' A' ' 29' ' ' ALA . 31.6 mt -69.85 -42.11 74.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -60.68 -33.28 72.61 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 0.0 109.296 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.554 ' CG2' HD13 ' A' ' 16' ' ' LEU . 17.7 mt -64.72 116.15 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.919 . . . . 0.0 109.216 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.487 ' OXT' ' HB1' ' A' ' 26' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 118.088 -0.958 . . . . 0.0 109.577 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 1.01 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.464 ' N ' HD12 ' A' ' 4' ' ' LEU . 63.2 m-20 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 57.59 51.38 9.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.928 . . . . 0.0 109.362 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.458 ' HG2' ' O ' ' A' ' 1' ' ' ASN . 0.0 OUTLIER -170.05 -37.32 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.28 -0.888 . . . . 0.0 109.27 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.661 HD13 ' OE1' ' A' ' 71' ' ' GLN . 1.2 mt -74.35 -33.57 63.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.207 -0.933 . . . . 0.0 109.252 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.99 -34.92 62.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.569 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -53.35 57.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.666 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.443 ' O ' ' C ' ' A' ' 8' ' ' LYS . 1.1 mm-40 -53.92 -79.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.275 -0.891 . . . . 0.0 109.959 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER -41.32 -60.74 1.18 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.505 -0.747 . . . . 0.0 109.741 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 124.13 33.99 0.75 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.651 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 57.9 m -74.13 -31.53 62.78 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -1.167 . . . . 0.0 109.385 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.76 -2.04 18.85 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.89 . . . . 0.0 109.81 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.22 -34.04 75.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 7.5 m -126.51 4.69 6.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.599 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.469 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 16.5 m-70 -112.73 -175.56 2.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.02 -1.05 . . . . 0.0 109.766 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.846 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 2.2 m-20 166.69 136.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.513 -0.742 . . . . 0.0 109.044 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.658 HD22 HG21 ' A' ' 79' ' ' ILE . 12.2 mt -56.92 -48.14 78.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.105 -0.997 . . . . 0.0 109.882 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 17' ' ' LYS . 36.0 tttm -130.75 45.81 2.76 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.267 -0.896 . . . . 0.0 109.898 -179.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.846 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.78 68.53 1.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.123 -0.985 . . . . 0.0 109.642 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.8 tmtt? -61.47 98.26 0.08 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -109.07 -97.76 0.39 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 0.0 109.283 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 38.5 t -78.77 -52.72 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.044 -1.035 . . . . 0.0 108.986 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -95.51 178.36 35.3 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.515 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.2 Cg_endo -78.87 122.66 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.591 2.194 . . . . 0.0 110.366 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -46.31 138.15 5.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.099 -1.001 . . . . 0.0 109.359 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.549 ' CD1' HG12 ' A' ' 76' ' ' ILE . 20.5 m-85 -46.38 -39.63 10.69 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.261 -0.9 . . . . 0.0 110.041 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.3 -51.06 69.17 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.148 -0.97 . . . . 0.0 109.953 -179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -59.79 -27.63 66.74 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 110.067 -179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.1 t -66.53 -58.42 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.11 -0.994 . . . . 0.0 109.658 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.56 -29.82 66.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.351 -0.843 . . . . 0.0 109.789 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -67.61 -38.28 83.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -0.976 . . . . 0.0 109.651 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.531 ' HG3' ' CH2' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -68.69 -16.25 63.77 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.078 -1.014 . . . . 0.0 109.504 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.716 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 9.0 m-85 -123.64 -144.42 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.233 -0.917 . . . . 0.0 109.084 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.716 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 78.96 107.46 0.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.195 -0.941 . . . . 0.0 109.417 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.62 -13.42 62.61 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -61.06 -163.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.433 -1.039 . . . . 0.0 109.345 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.1 ttmt -77.95 -29.69 50.0 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.141 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 6.5 t0 178.77 70.86 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.295 -0.878 . . . . 0.0 109.294 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.44 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . . . -64.18 -11.98 35.98 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 109.654 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.63 -65.8 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.215 -0.928 . . . . 0.0 109.521 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -56.87 -39.8 75.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.168 -0.958 . . . . 0.0 109.28 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -64.12 -54.18 37.97 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.437 -0.789 . . . . 0.0 109.581 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 46' ' ' ILE . 15.3 mt -47.7 -68.48 0.18 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.241 -0.912 . . . . 0.0 109.603 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.808 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.41 -38.87 2.96 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.33 -0.856 . . . . 0.0 109.728 -179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -58.33 -48.27 84.68 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -84.63 -0.96 55.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.233 -1.157 . . . . 0.0 109.751 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.808 HD12 ' HA ' ' A' ' 43' ' ' ALA . 65.8 mt -85.82 -41.13 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.184 -0.948 . . . . 0.0 109.645 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.44 -23.12 60.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 0.0 109.751 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -107.08 -53.2 2.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.195 -0.941 . . . . 0.0 109.842 -179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 99.01 -120.14 6.75 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.37 -146.68 18.28 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.475 ' HA ' ' CGD' ' A' ' 81' ' ' HEC . 5.6 t 176.04 159.57 0.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 137.82 -12.57 3.66 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.3 t -101.57 -31.01 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.261 -1.141 . . . . 0.0 109.524 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.531 ' CH2' ' HG3' ' A' ' 31' ' ' LYS . 97.9 m95 -109.09 -11.41 14.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.71 -144.84 12.5 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.7 p -102.39 -13.92 17.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.296 -1.12 . . . . 0.0 109.643 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.559 HG12 HMD2 ' A' ' 81' ' ' HEC . 59.7 t -46.38 106.62 0.59 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.23 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.96 110.54 3.06 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.539 2.159 . . . . 0.0 110.809 -179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.434 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 2.5 ttt -87.57 139.24 31.55 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.365 -0.834 . . . . 0.0 109.028 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.2 Cg_endo -78.6 155.75 27.88 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.514 2.143 . . . . 0.0 110.571 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 35.8 Cg_endo -77.9 132.04 11.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.613 2.209 . . . . 0.0 110.475 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.466 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 48.2 mm-40 -97.12 161.45 13.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.221 -0.924 . . . . 0.0 109.376 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 m120 -98.47 60.03 1.33 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.344 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.8 m -106.51 151.08 8.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.287 -0.883 . . . . 0.0 109.47 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.66 175.91 8.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.226 -0.921 . . . . 0.0 109.104 179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.09 -20.99 64.99 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.154 -0.966 . . . . 0.0 109.397 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.498 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -75.63 -56.69 4.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.319 -0.863 . . . . 0.0 109.203 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.469 ' O ' HD12 ' A' ' 72' ' ' LEU . 1.5 mm-40 -62.31 -31.0 71.55 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.117 -0.99 . . . . 0.0 109.37 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.41 -36.06 71.22 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.309 -0.87 . . . . 0.0 109.373 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.557 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -68.46 -28.79 67.36 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.254 -0.904 . . . . 0.0 109.357 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.661 ' OE1' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -80.36 -25.89 38.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.397 -0.814 . . . . 0.0 109.234 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.5 ' N ' ' HG3' ' A' ' 71' ' ' GLN . 6.2 mt -80.94 -24.46 38.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 108.921 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.38 -40.64 15.21 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -32.42 65.06 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.522 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 18.2 t90 -76.49 -47.91 21.31 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.549 HG12 ' CD1' ' A' ' 25' ' ' TYR . 55.6 mt -62.81 -25.57 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.319 -0.863 . . . . 0.0 109.425 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 77' ' ' LEU . 20.4 mt -77.9 -51.0 11.11 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.828 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.7 m -59.57 -21.11 59.85 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.694 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.658 HG21 HD22 ' A' ' 16' ' ' LEU . 10.0 mt -67.52 140.2 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.131 -0.981 . . . . 0.0 109.283 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.1 tttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.418 179.917 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.762 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -103.59 88.63 3.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.304 -0.873 . . . . 0.0 109.495 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 179.74 -48.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.206 -0.934 . . . . 0.0 109.574 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.2 pp -69.85 -32.49 70.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.2 -0.938 . . . . 0.0 109.498 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.21 -20.03 60.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.587 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.87 -49.54 10.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.19 -0.943 . . . . 0.0 109.556 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -24.79 67.67 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.345 -0.847 . . . . 0.0 109.888 -179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.67 -52.71 16.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.144 -0.973 . . . . 0.0 109.67 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 126.79 58.82 0.14 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.518 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 11.9 m -112.85 -37.62 4.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -1.157 . . . . 0.0 109.457 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.4 mmt -65.15 -13.78 58.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.202 -0.936 . . . . 0.0 109.838 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.76 -31.41 64.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.564 -179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 21' ' ' VAL . 12.9 m -127.9 18.61 6.66 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.508 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 29.8 m-70 -136.68 -174.52 3.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.0 109.763 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.667 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 164.29 124.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.361 -0.837 . . . . 0.0 109.332 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.815 HD22 HG21 ' A' ' 79' ' ' ILE . 75.4 mt -43.59 -53.39 5.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 109.707 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.7 mttt -130.09 43.65 3.09 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.353 -0.842 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.6 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . . . -158.1 58.56 0.47 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.237 -0.914 . . . . 0.0 109.58 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.7 pttt -54.52 128.69 33.19 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.429 -0.794 . . . . 0.0 109.718 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.3 mtmp? -122.81 -105.45 0.37 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.18 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.45 ' HB ' ' CB ' ' A' ' 13' ' ' CYS . 36.8 t -65.14 -30.36 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.779 -1.201 . . . . 0.0 108.706 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -120.0 -175.5 15.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.584 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.0 Cg_endo -78.52 152.06 26.05 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.486 2.124 . . . . 0.0 110.108 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.667 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -73.04 144.09 47.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.132 -0.98 . . . . 0.0 109.184 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.679 ' HB2' HD23 ' A' ' 16' ' ' LEU . 23.9 m-85 -53.92 -41.09 67.32 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.279 -0.888 . . . . 0.0 109.954 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.56 56.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.162 -0.961 . . . . 0.0 110.036 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -55.62 -31.81 62.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.277 -0.889 . . . . 0.0 109.971 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 56.5 t -68.65 -58.07 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.276 -0.89 . . . . 0.0 109.828 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.68 -49.88 26.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.207 -0.933 . . . . 0.0 109.611 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -42.02 81.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.175 -0.953 . . . . 0.0 109.662 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 -42.4 82.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.31 -0.869 . . . . 0.0 109.628 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 73.6 m-85 -106.55 -143.63 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.156 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.737 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 83.55 -37.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.386 -0.821 . . . . 0.0 110.039 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -88.7 27.23 7.36 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -114.55 157.41 23.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -1.149 . . . . 0.0 109.496 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -91.56 24.94 2.83 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.185 -0.947 . . . . 0.0 109.375 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -178.85 44.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.889 . . . . 0.0 109.402 -179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.547 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -72.52 -19.57 61.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.463 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.428 HG23 ' H ' ' A' ' 39' ' ' VAL . 2.0 t -73.9 -41.09 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.275 -0.891 . . . . 0.0 109.307 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.12 -45.19 58.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.295 -0.878 . . . . 0.0 109.292 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -59.34 -53.81 53.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.283 -0.886 . . . . 0.0 109.62 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.547 HD12 ' O ' ' A' ' 38' ' ' ALA . 14.2 mt -57.55 -69.65 0.16 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.868 . . . . 0.0 109.571 -179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -40.43 -28.56 0.07 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.532 -0.73 . . . . 0.0 109.852 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 42' ' ' LEU . . . -71.36 -56.94 6.41 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.74 -7.85 30.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.39 -1.065 . . . . 0.0 109.475 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 43' ' ' ALA . 54.5 mt -84.53 -54.79 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.334 -0.854 . . . . 0.0 109.392 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -13.25 61.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.276 -0.89 . . . . 0.0 109.772 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.25 -72.68 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.066 -1.021 . . . . 0.0 109.752 -179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 103.74 -179.32 25.31 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 145.81 -147.47 18.52 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.9 p -162.89 138.15 6.77 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.226 -1.161 . . . . 0.0 109.55 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 143.58 -22.25 2.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 11.2 t -86.16 -30.34 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.214 -1.168 . . . . 0.0 109.538 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 84.7 m95 -131.61 23.63 4.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.162 -0.961 . . . . 0.0 109.809 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 124.17 -160.86 18.72 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 0.7 OUTLIER -92.46 8.44 38.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -1.122 . . . . 0.0 109.748 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -66.88 112.92 10.96 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.21 -0.931 . . . . 0.0 109.441 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.521 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 37.1 Cg_endo -80.59 78.6 3.61 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.487 2.124 . . . . 0.0 110.445 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.46 ' HG2' ' HD2' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -58.37 133.94 85.1 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.075 -1.016 . . . . 0.0 108.921 179.872 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.46 ' HD2' ' HG2' ' A' ' 59' ' ' MET . 35.9 Cg_endo -79.18 162.96 25.53 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.527 2.151 . . . . 0.0 110.417 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.3 137.33 14.96 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.848 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 3.6 mp0 -100.03 -170.57 1.9 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.131 -0.98 . . . . 0.0 109.438 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -120.14 69.82 0.86 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.69 152.38 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.53 172.65 13.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.422 -0.799 . . . . 0.0 109.239 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -66.54 -35.48 80.35 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.201 -0.937 . . . . 0.0 109.381 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HG3' ' A' ' 70' ' ' LYS . . . -69.28 -44.81 71.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.239 -0.913 . . . . 0.0 109.481 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -63.39 -35.61 80.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.062 -1.024 . . . . 0.0 109.283 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.605 ' HA ' HD12 ' A' ' 72' ' ' LEU . . . -62.06 -42.89 99.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.34 -0.85 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.597 ' HG3' ' N ' ' A' ' 71' ' ' GLN . 0.1 OUTLIER -66.46 -29.54 69.69 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.219 -0.926 . . . . 0.0 109.344 -179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.597 ' N ' ' HG3' ' A' ' 70' ' ' LYS . 1.1 tm0? -78.67 -22.55 46.62 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.33 -0.856 . . . . 0.0 109.462 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 69' ' ' ALA . 4.8 mt -79.43 -37.43 37.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.243 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.56 -31.84 32.46 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.281 -0.887 . . . . 0.0 108.683 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.04 -33.43 59.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.519 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 5.6 t90 -76.06 -45.89 31.94 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.403 -0.811 . . . . 0.0 108.945 179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.622 ' HA ' HD12 ' A' ' 79' ' ' ILE . 67.3 mt -62.52 -37.91 80.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.136 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.4 ' HA ' HD23 ' A' ' 77' ' ' LEU . 14.0 mt -66.47 -39.34 88.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.364 -0.835 . . . . 0.0 109.228 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.88 -25.99 67.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.324 -0.86 . . . . 0.0 109.184 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.815 HG21 HD22 ' A' ' 16' ' ' LEU . 38.0 mt -62.77 151.61 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 0.0 109.21 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.6 tttt . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.554 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.947 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.571 ' O ' ' CE2' ' A' ' 75' ' ' TRP . 4.2 m-20 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.468 0.651 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -165.3 62.94 0.12 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.418 -0.801 . . . . 0.0 109.246 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -49.42 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.269 -0.894 . . . . 0.0 109.441 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' LYS . 2.5 pp -71.26 -12.04 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.333 -0.854 . . . . 0.0 109.533 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.8 -33.26 11.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.275 -0.891 . . . . 0.0 109.707 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.7 tttm -54.78 -71.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.541 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.82 -34.01 64.97 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.588 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -45.42 -38.78 6.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 0.0 109.637 -179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 99.32 24.91 9.82 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 18.8 m -94.31 -41.05 9.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.345 -1.091 . . . . 0.0 109.551 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.1 mmt -58.27 -15.01 8.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.267 -0.895 . . . . 0.0 109.796 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -56.16 -42.99 77.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 0.0 109.546 -179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.8 m -112.73 19.85 17.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 36.3 m-70 -136.69 -171.99 3.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.055 -1.028 . . . . 0.0 110.042 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.871 ' CB ' ' HB3' ' A' ' 18' ' ' ALA . 0.2 OUTLIER 164.68 126.61 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 0.0 109.016 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.556 HD22 HD13 ' A' ' 79' ' ' ILE . 11.1 mt -41.64 -55.4 2.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.344 -0.847 . . . . 0.0 109.806 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -130.82 46.11 2.72 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.721 -0.792 . . . . 0.0 109.824 -179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.871 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -145.84 81.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -0.96 . . . . 0.0 109.417 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt -53.02 108.97 0.37 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 0.0 109.825 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 21' ' ' VAL . 3.4 tttp -114.06 -147.2 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 0.0 108.869 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' LYS . 56.5 t -46.01 -30.95 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.963 -1.085 . . . . 0.0 108.746 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.11 -178.67 16.69 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.35 152.56 26.98 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.556 2.17 . . . . 0.0 110.525 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.604 ' HB1' ' O ' ' A' ' 15' ' ' ASP . . . -72.6 136.46 45.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.359 -0.838 . . . . 0.0 109.222 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.596 ' HB3' HG23 ' A' ' 76' ' ' ILE . 12.1 m-85 -52.6 -40.09 62.3 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.2 -0.937 . . . . 0.0 109.641 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.83 -50.47 73.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.3 -0.875 . . . . 0.0 109.629 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -57.3 -35.95 70.46 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -0.878 . . . . 0.0 109.592 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.15 -52.08 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 109.515 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -51.91 -40.37 60.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.652 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.45 -41.71 98.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 0.0 109.545 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -37.61 88.02 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.254 -0.904 . . . . 0.0 109.877 -179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.715 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 4.3 m-85 -106.88 -142.65 0.38 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -0.964 . . . . 0.0 109.544 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 80.98 107.38 0.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.84 -12.07 68.99 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.959 -1.656 . . . . 0.0 108.959 -179.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.66 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 7.9 ttt180 -63.03 146.05 54.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.444 -1.033 . . . . 0.0 109.491 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' C ' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -43.17 -56.42 3.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.321 -0.862 . . . . 0.0 109.468 179.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -128.35 68.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.368 -0.832 . . . . 0.0 109.392 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' ARG . . . -78.23 -27.1 47.59 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.454 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 44.5 t -75.48 -46.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.067 -1.021 . . . . 0.0 108.99 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -69.87 -38.16 76.31 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.266 -0.896 . . . . 0.0 109.056 179.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 11.5 t80 -62.2 -56.24 20.61 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.37 -0.831 . . . . 0.0 109.213 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 42' ' ' LEU . 10.7 mt -51.91 -69.62 0.11 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.345 -0.847 . . . . 0.0 109.418 179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 42' ' ' LEU . . . -42.6 -30.71 0.38 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.449 -0.782 . . . . 0.0 109.416 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.04 25.15 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -74.44 -4.32 35.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.266 -1.138 . . . . 0.0 109.688 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.536 HG12 ' CMA' ' A' ' 81' ' ' HEC . 38.5 mt -87.63 -40.38 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.449 ' HE2' ' O ' ' A' ' 64' ' ' VAL . 0.3 OUTLIER -101.09 15.5 28.5 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.131 -0.98 . . . . 0.0 109.607 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -125.01 -66.7 0.95 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.165 -0.959 . . . . 0.0 109.505 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 105.13 175.15 24.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 138.94 -157.22 24.71 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 54.6 p -163.33 145.89 10.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.319 -1.107 . . . . 0.0 109.539 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 140.89 -9.16 2.79 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.438 HG11 ' OH ' ' A' ' 32' ' ' TYR . 29.4 t -99.45 -24.14 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -1.139 . . . . 0.0 109.716 -179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -125.78 -11.42 6.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 110.006 -179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.15 -130.09 3.16 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 11.5 t -113.16 51.6 0.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.446 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.444 ' HB ' HMD1 ' A' ' 81' ' ' HEC . 0.0 OUTLIER -112.48 101.8 53.13 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.314 -0.866 . . . . 0.0 109.255 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 34.4 Cg_endo -76.66 78.18 3.43 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.427 2.084 . . . . 0.0 110.33 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.464 ' HG3' ' HD2' ' A' ' 60' ' ' PRO . 13.1 ttt -57.54 138.31 81.73 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.313 -0.867 . . . . 0.0 109.654 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.464 ' HD2' ' HG3' ' A' ' 59' ' ' MET . 36.4 Cg_endo -79.74 172.69 13.87 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.507 2.138 . . . . 0.0 110.22 179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.61 172.99 13.58 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.608 2.206 . . . . 0.0 110.342 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.579 ' CG ' HBB2 ' A' ' 81' ' ' HEC . 80.1 mm-40 -131.02 177.48 7.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.209 -0.932 . . . . 0.0 109.542 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -109.34 52.07 0.73 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.901 . . . . 0.0 109.296 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.837 HG12 ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -122.01 163.49 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.602 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 67' ' ' ALA . 1.6 p -96.57 144.33 26.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.351 -0.843 . . . . 0.0 108.774 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 65' ' ' THR . 0.7 OUTLIER -42.98 -26.09 0.13 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.221 -0.925 . . . . 0.0 109.913 -179.742 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' THR . . . -63.94 -65.58 0.66 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.14 -0.975 . . . . 0.0 109.618 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.837 ' OE1' HG12 ' A' ' 64' ' ' VAL . 1.1 pt-20 -57.84 -35.24 70.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.102 -0.999 . . . . 0.0 109.661 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.69 -30.54 71.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.97 -1.081 . . . . 0.0 108.568 179.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -64.19 -53.98 40.79 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.46 -0.775 . . . . 0.0 109.205 179.675 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.517 ' O ' ' HB3' ' A' ' 75' ' ' TRP . 0.1 OUTLIER -61.68 -22.57 65.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.446 -0.784 . . . . 0.0 109.662 -179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.759 HD23 ' CE3' ' A' ' 75' ' ' TRP . 18.6 mt -78.65 -25.66 45.03 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.186 -0.946 . . . . 0.0 109.099 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.48 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -79.26 -52.89 7.53 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -63.41 -35.68 81.23 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.759 ' CE3' HD23 ' A' ' 72' ' ' LEU . 6.1 t90 -64.15 -50.93 66.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.474 -0.766 . . . . 0.0 109.191 179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.616 HD12 ' O ' ' A' ' 72' ' ' LEU . 19.7 mt -59.91 -33.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.962 . . . . 0.0 109.592 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 95.2 mt -63.99 -38.42 91.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.09 -1.006 . . . . 0.0 109.671 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.2 t -65.61 -38.49 89.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.163 -0.961 . . . . 0.0 109.388 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.556 HD13 HD22 ' A' ' 16' ' ' LEU . 50.9 mt -57.35 117.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.208 -0.933 . . . . 0.0 109.525 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.916 -1.04 . . . . 0.0 109.431 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.879 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 121.357 0.598 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 179.93 42.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.923 . . . . 0.0 109.504 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -117.66 -31.39 5.19 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.191 -0.943 . . . . 0.0 109.567 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.69 HD21 ' OE1' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -84.46 -20.97 30.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.297 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.498 ' CB ' ' CZ3' ' A' ' 75' ' ' TRP . . . -87.26 -17.3 32.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.27 -0.894 . . . . 0.0 109.276 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.33 -46.82 6.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.88 . . . . 0.0 109.546 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -67.3 -27.29 67.05 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.229 -0.92 . . . . 0.0 109.592 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.755 ' HG2' HBB1 ' A' ' 81' ' ' HEC . 0.3 OUTLIER -68.01 -54.03 21.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 109.342 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 129.09 32.08 0.6 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.42 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 33.9 m -83.11 -31.01 27.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.07 -1.253 . . . . 0.0 109.267 179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.505 ' HE1' ' CD1' ' A' ' 16' ' ' LEU . 11.4 mmt -73.79 -15.36 61.19 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.328 -0.857 . . . . 0.0 109.676 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.39 -40.74 68.47 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.201 -0.937 . . . . 0.0 109.342 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.458 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 7.4 m -118.42 33.85 5.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.141 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' A' ' 15' ' ' ASP . 27.5 m-70 -140.09 -172.98 3.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.116 -0.99 . . . . 0.0 109.685 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.547 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 5.3 t0 175.58 137.21 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.499 -0.751 . . . . 0.0 109.161 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.723 ' O ' ' HB2' ' A' ' 26' ' ' ALA . 8.5 mp -77.3 -21.08 54.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.732 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.442 ' O ' ' O ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -113.74 38.02 3.08 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.125 -0.985 . . . . 0.0 110.003 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.887 ' HA ' ' HB2' ' A' ' 24' ' ' ALA . . . 49.31 98.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.369 -0.832 . . . . 0.0 110.021 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 15' ' ' ASP . 0.0 OUTLIER 171.04 88.34 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.233 -0.917 . . . . 0.0 109.423 179.579 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 15' ' ' ASP . 1.2 tptt 175.26 -153.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.398 -0.814 . . . . 0.0 109.218 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 13' ' ' CYS . 17.8 t -89.69 -62.76 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.111 -0.993 . . . . 0.0 109.295 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -72.15 -157.97 3.58 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.6 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 36.1 Cg_endo -78.86 180.0 5.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.531 2.154 . . . . 0.0 110.178 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 18' ' ' ALA . . . -109.95 135.78 50.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.166 -0.959 . . . . 0.0 109.41 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -52.41 -38.27 58.64 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.274 -0.892 . . . . 0.0 109.575 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 16' ' ' LEU . . . -61.36 -49.02 78.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -0.953 . . . . 0.0 109.512 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -63.8 -25.25 68.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.373 -0.83 . . . . 0.0 109.818 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 24' ' ' ALA . 81.7 t -65.81 -58.03 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.249 -0.907 . . . . 0.0 109.49 -179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.69 -21.63 66.79 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.29 -0.881 . . . . 0.0 109.581 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -78.17 -30.1 48.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -71.25 -33.53 69.91 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.595 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.72 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 21.6 m-85 -101.44 -123.44 0.17 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 109.229 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.72 ' HB3' ' O ' ' A' ' 32' ' ' TYR . . . 81.24 109.95 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.066 -1.021 . . . . 0.0 109.659 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.17 -14.22 62.64 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 19.4 ttt180 -93.45 135.2 34.94 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.39 -1.065 . . . . 0.0 109.73 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.98 -11.48 55.4 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.363 -0.835 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 1.7 m-20 -96.64 17.24 16.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 109.396 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.403 ' O ' HD12 ' A' ' 42' ' ' LEU . . . -73.69 -24.33 59.93 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.172 -0.955 . . . . 0.0 109.573 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.0 t -81.66 -53.38 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.407 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -62.83 -36.73 84.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.146 -0.972 . . . . 0.0 109.242 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 15.7 t80 -65.73 -65.85 0.62 Allowed 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.221 -0.925 . . . . 0.0 109.412 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 77' ' ' LEU . 4.0 mt -51.03 -64.38 0.83 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.316 -0.865 . . . . 0.0 109.379 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.943 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -43.66 -31.87 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.559 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -62.11 -56.51 21.85 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HB3' HBA1 ' A' ' 81' ' ' HEC . 0.1 OUTLIER -75.31 -5.83 46.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.227 -1.161 . . . . 0.0 109.536 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.943 HD12 ' HA ' ' A' ' 43' ' ' ALA . 70.0 mt -79.63 -37.37 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.461 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt -99.69 21.47 12.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.39 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.18 -71.67 0.19 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 0.0 109.577 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 106.51 -130.15 10.05 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 111.0 -132.0 10.68 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.25 143.57 0.14 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.323 -1.104 . . . . 0.0 109.413 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 122.68 -0.89 10.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG11 ' O2A' ' A' ' 81' ' ' HEC . 21.9 t -107.61 -6.85 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.193 -1.18 . . . . 0.0 109.607 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.9 m95 -152.66 33.15 0.5 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.64 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.23 -146.56 18.47 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.403 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 12.3 p -109.55 16.55 22.14 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.304 -1.116 . . . . 0.0 109.563 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.437 ' HB ' HMD1 ' A' ' 81' ' ' HEC . 2.2 t -87.17 115.11 61.57 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.291 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLY . 36.0 Cg_endo -78.38 150.34 25.26 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.474 2.116 . . . . 0.0 110.605 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.454 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 4.0 ttt -127.95 138.89 33.89 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 59' ' ' MET . 36.5 Cg_endo -80.08 150.92 20.71 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.547 2.165 . . . . 0.0 110.643 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.69 146.21 21.01 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.762 2.308 . . . . 0.0 110.128 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.933 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 38.3 mm-40 -108.07 172.52 6.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.069 -1.019 . . . . 0.0 109.704 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -98.86 50.07 0.96 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.317 -0.865 . . . . 0.0 109.663 -179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 64' ' ' VAL . 21.2 m -93.05 150.83 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.612 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 45.1 p -78.4 -172.57 2.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.275 -0.891 . . . . 0.0 109.024 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.55 -38.37 55.12 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.186 -0.946 . . . . 0.0 109.537 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -66.61 -43.24 85.34 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.202 -0.936 . . . . 0.0 109.138 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -57.94 -44.59 87.02 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.906 . . . . 0.0 109.323 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.22 79.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.903 . . . . 0.0 109.192 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -44.45 95.04 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 109.709 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.69 ' OE1' HD21 ' A' ' 4' ' ' LEU . 1.5 tm0? -70.07 -24.61 63.27 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.247 -0.908 . . . . 0.0 109.774 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.2 mt -76.95 -24.52 52.36 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.114 -0.991 . . . . 0.0 109.314 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -84.36 -51.64 6.81 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.188 -0.945 . . . . 0.0 108.642 179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -66.04 -27.73 68.32 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.34 -0.85 . . . . 0.0 108.724 179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.525 ' CB ' ' O ' ' A' ' 71' ' ' GLN . 24.6 t90 -78.47 -50.15 12.15 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.23 -0.919 . . . . 0.0 109.37 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.8 mt -66.49 -14.77 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.193 -0.942 . . . . 0.0 109.261 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.515 HD21 ' CD1' ' A' ' 42' ' ' LEU . 68.0 mt -89.16 -41.01 12.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.127 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.25 -42.43 88.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 109.156 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.531 HG21 ' HG ' ' A' ' 16' ' ' LEU . 9.0 mt -46.02 147.51 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -0.887 . . . . 0.0 109.03 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 mtpt . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.489 -179.932 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.933 HBB2 ' HG3' ' A' ' 62' ' ' GLN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 46.34 86.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.387 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 179.17 -54.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.335 -0.853 . . . . 0.0 109.32 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.778 HD21 ' OE1' ' A' ' 71' ' ' GLN . 4.6 pp -68.39 -20.81 64.71 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.704 ' N ' HD12 ' A' ' 4' ' ' LEU . . . -86.38 -10.74 53.73 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.321 -0.862 . . . . 0.0 109.358 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -83.75 -40.56 18.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.974 . . . . 0.0 109.223 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -54.8 -18.71 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.575 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.4 mmtt -87.32 -50.19 6.74 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.194 -0.941 . . . . 0.0 109.378 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 116.9 30.36 1.99 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.544 ' SG ' HMB1 ' A' ' 81' ' ' HEC . 21.8 m -65.8 -37.67 86.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.145 -1.209 . . . . 0.0 109.474 179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 24.7 mmt -59.59 -15.07 16.04 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 109.56 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.51 -41.79 63.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.196 -0.94 . . . . 0.0 109.166 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.1 m -125.28 8.15 7.84 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.341 -0.849 . . . . 0.0 109.268 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.498 ' O ' ' CB ' ' A' ' 15' ' ' ASP . 14.0 m-70 -122.32 -175.1 3.05 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.149 -179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.613 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.7 OUTLIER 164.06 147.94 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.481 HD22 HD13 ' A' ' 79' ' ' ILE . 10.3 mt -63.37 -52.96 59.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 110.368 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -130.66 45.25 2.84 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.053 -1.029 . . . . 0.0 110.517 -178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.5 ' HB3' ' CB ' ' A' ' 15' ' ' ASP . . . -140.44 55.1 1.61 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.087 -1.008 . . . . 0.0 109.653 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -47.25 110.83 0.34 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.298 -0.876 . . . . 0.0 109.839 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.405 ' HG2' HG23 ' A' ' 21' ' ' VAL . 16.4 tttt -122.52 -91.39 0.56 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.246 -0.909 . . . . 0.0 109.008 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.405 HG23 ' HG2' ' A' ' 20' ' ' LYS . 44.5 t -86.22 -57.2 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 120.984 -1.073 . . . . 0.0 108.814 179.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -92.39 177.17 39.13 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.591 ' HB3' ' CE3' ' A' ' 54' ' ' TRP . 35.3 Cg_endo -78.18 124.45 6.62 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.59 2.193 . . . . 0.0 110.529 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.761 ' O ' HG23 ' A' ' 28' ' ' VAL . . . -54.41 151.53 7.54 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.34 -0.85 . . . . 0.0 109.454 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.454 ' OH ' ' HB3' ' A' ' 10' ' ' CYS . 24.9 m-85 -61.52 -47.98 83.1 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.24 -0.912 . . . . 0.0 109.806 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -48.55 -51.73 26.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -0.881 . . . . 0.0 109.708 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -61.64 -38.24 86.99 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.211 -0.93 . . . . 0.0 109.616 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.761 HG23 ' O ' ' A' ' 24' ' ' ALA . 59.0 t -55.24 -44.54 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.185 -0.947 . . . . 0.0 109.311 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.682 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -62.3 -43.58 98.5 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.238 -0.914 . . . . 0.0 109.132 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -67.13 -14.45 62.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.293 -0.879 . . . . 0.0 109.096 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? -83.38 -22.27 32.82 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.279 -0.888 . . . . 0.0 109.665 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.996 ' CE2' HD21 ' A' ' 42' ' ' LEU . 61.1 m-85 -123.13 134.45 54.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.144 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' TYR . . . 175.32 107.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.34 -0.85 . . . . 0.0 109.003 -179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.65 -17.06 46.9 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.01 134.95 56.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.592 -0.946 . . . . 0.0 108.989 179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -28.86 70.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.983 -179.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -131.82 61.79 1.65 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.053 -1.029 . . . . 0.0 109.709 -179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.99 -32.43 26.99 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.267 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.0 t -74.53 -46.08 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.352 -0.842 . . . . 0.0 109.378 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -70.98 -47.3 59.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.513 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ASP . 54.7 t80 -55.47 -55.58 30.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.275 -0.89 . . . . 0.0 109.48 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.996 HD21 ' CE2' ' A' ' 32' ' ' TYR . 13.5 mt -48.66 -56.85 7.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 109.318 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.592 ' HA ' HD12 ' A' ' 46' ' ' ILE . . . -47.21 -40.94 17.31 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.368 -0.833 . . . . 0.0 109.494 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -60.86 -46.64 94.12 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' HD3' ' HA ' ' A' ' 45' ' ' LYS . 51.8 mmtt -82.86 4.24 26.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.153 -1.204 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 43' ' ' ALA . 33.6 mt -95.42 -38.46 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.898 . . . . 0.0 109.32 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.91 8.96 18.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.522 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.66 -46.19 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 109.641 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 59' ' ' MET . . . 81.85 -104.77 2.47 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 58' ' ' PRO . . . 98.44 -173.8 27.7 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.511 ' HB2' ' CA ' ' A' ' 58' ' ' PRO . 8.1 t -135.41 134.53 39.78 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.22 -1.165 . . . . 0.0 109.709 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 136.2 -27.68 2.99 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 61.4 t -85.98 -11.7 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -1.099 . . . . 0.0 109.335 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.591 ' CE3' ' HB3' ' A' ' 23' ' ' PRO . 90.5 m95 -139.77 17.51 2.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 109.881 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.59 -156.73 15.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -95.61 41.72 1.1 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.276 -1.132 . . . . 0.0 109.636 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' O ' HBD2 ' A' ' 81' ' ' HEC . 1.3 t -122.18 109.32 33.47 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 109.04 179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.511 ' CA ' ' HB2' ' A' ' 51' ' ' SER . 35.7 Cg_endo -77.86 143.4 20.81 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.444 2.096 . . . . 0.0 111.202 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.415 ' HG2' ' N ' ' A' ' 60' ' ' PRO . 2.5 ttt -110.46 139.48 21.58 Favored Pre-proline 0 N--CA 1.49 1.56 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' N ' ' HG2' ' A' ' 59' ' ' MET . 36.0 Cg_endo -78.76 152.83 25.71 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.419 2.08 . . . . 0.0 110.46 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.13 153.67 28.54 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.645 2.23 . . . . 0.0 110.157 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.821 ' HG3' HBB2 ' A' ' 81' ' ' HEC . 18.0 mm-40 -118.86 -166.62 1.26 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.227 -0.92 . . . . 0.0 109.56 -179.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -113.19 77.62 1.07 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.353 -0.842 . . . . 0.0 109.564 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.6 m -133.26 151.04 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.15 160.71 19.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 109.108 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.97 -37.03 63.52 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.172 -0.955 . . . . 0.0 109.457 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.09 -44.32 96.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.057 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 71' ' ' GLN . 0.5 OUTLIER -59.81 -52.98 63.14 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.329 -0.857 . . . . 0.0 109.092 179.798 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 43' ' ' ALA . . . -49.48 -31.35 9.84 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 108.741 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -66.56 -46.03 77.41 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.43 -0.794 . . . . 0.0 109.244 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.778 ' OE1' HD21 ' A' ' 4' ' ' LEU . 0.1 OUTLIER -69.68 -18.13 63.54 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.241 -0.912 . . . . 0.0 109.384 -179.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.763 ' O ' HD12 ' A' ' 76' ' ' ILE . 6.0 mt -82.32 -28.92 31.37 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.341 -0.849 . . . . 0.0 109.05 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.63 ' O ' HD12 ' A' ' 77' ' ' LEU . . . -86.84 -26.72 23.88 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 0.0 108.717 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -82.61 -36.35 26.19 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.301 -0.999 . . . . 0.0 108.301 179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' TRP . . . . . 0.499 ' HB3' ' O ' ' A' ' 71' ' ' GLN . 9.7 t90 -78.36 -41.87 32.12 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.763 HD12 ' O ' ' A' ' 72' ' ' LEU . 50.3 mt -65.86 -40.97 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.185 -0.947 . . . . 0.0 109.248 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.682 HD23 ' HA ' ' A' ' 29' ' ' ALA . 23.4 mt -66.83 -40.26 87.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.246 -0.909 . . . . 0.0 109.067 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -38.13 83.07 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.181 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 HD13 HD22 ' A' ' 16' ' ' LEU . 12.5 mt -58.08 111.59 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.321 -0.862 . . . . 0.0 109.084 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.418 ' C ' ' O ' ' A' ' 79' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HEC . . . . . 0.873 HBC3 HMC1 ' A' ' 81' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_